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ABSTRACT 
Pyruvate kinase is a useful model system for studying the control of 
gene expression as its four isoenzymes are expressed both tissue 
specifically and developmentally in mammals. Two genes, Pk-1 and Pk-3, 
each code for two of the isoenzymes. 
Putative regulatory mutations of Pk-1 were analysed immuno-
logically and genetically. Two were shown to be regulatory mutations. 
SWR - showed a tissue specific decrease in enzyme number in 
the liver. 
WiN - showed a systemic increase in enzyme number. 
A tissue specific structural gene mutation was also identifed. 
C3H/He and C57BL/6 were shown to differ structurally in the liver 
enzyme but not the blood enzyme with the C3H/He liver enzyme having a 
reduced activity. 
Three other activity variants, W, PKD and PKL, were shown to be 
systemic structural gene mutations. 
The regulatory mutations in SWR and MUN were shown to behave 
allelicly and to be linked to the structural locus. 
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CHAPTER 1 
INTRODUCTION PART 1 - PYRUVATE KINASE 
Pyruvate kinase (E.C.2.7.1.40) (PK) is the penultimate enzyme of the 
glycolytic pathway and is found ubiquitously in nature. It catalyses 
the formation of pyruvate from phospho enol pyruvate and adenosine 
5' diphosphate in the presence of K+ ,  Mg2+. Under physiological 
conditions the equilibrium is such that the reaction is virtually 
irreversible, one of three 'irreversible' enzymic reactions in the 
glycolytic pathway (Fig. 1.1). Enzyme activity is controlled by 
various forms of feedback inhibition, hormonal control, 
phosphorylation/ dephosphorylation and also at the level of gene 
expression. Regulation of gene expression is complicated due to the 
presence in higher animals, and even in some lower animals, of multiple 
forms of pyruvate kinase which are expressed with both temporal and 
tissue specificity. 
1 • 1 Isoenzymes of pyruvate kinase 
Pyruvate kinase occurs in multiple forms, the most extensively studied 
being the isoenzymes of mammalian systems. Four isoenzymes have been 
characterised which have been identified by several nomenclature 
systems. The one in most common use and followed here is that of 
Imamura and Tanaka (1972). 
Liver (major species) 	 PK-L 
Muscle 	 PK-M 1 
Kidney 	 PK-M2 
Red blood cells 	 PK-R 
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FIGURE 1.1. 
The glycolytic pathway. 
These isoenzymes are distributed throughout the body in a tissue 
specific manner and differ slightly in their molecular weight (Table 
1.1), electrophoretic mobility (Fig. 1.2), kinetics and regulation, 
the latter two of which are discussed in further detail in section 
1.4. 
The interrelationship between the isoenzymes, which was at first 
confusing, has recently been resolved by a series of biochemical and 
genetic experiments. 
Initial data on amino acid composition (Cardenas et al., 197Eâ 
indicated that PK-L and PK-M 1 were the products of separate genes. At 
the same time data linked PK-L and PK-R as being the possible products 
of a single gene due to their similar kinetics (Kahn et al., 1978) 
and reciprocal precipitation by specific L or R antisera (Marie et 
al., 1977. Genetic evidence for this link came from the decrease in 
both PK-R and PK-L but not PK-M 1 or PK-M2 in human PK deficiency 
disease (Bi:gly and Kohler, 1968). Trypsin digestion of PK-R was shown 
to produce a PK form indistinguishable biochemically from PK-L 
(Nakashima, 1974; Garreau et al., 1977; Kahn et al., 1979). These 
data led to the proposal that PK-L was a post-transcriptional 
modification of PK-R. Peptide mapping of all four isoenzymes (Saheki 
et al., 1982) (Fig. 1.3) revealed PK-R to have four extra peptides 
when compared to PK-L, but the NH  terminal amino acid was blocked in 
a similar manner in both isoenzymes, and the COOH terminal amino acid 
composition was identical. The four extra peptides are not believed to 
2 
2a 
Source Molecular wt n Reference 
Native Monomer 
Yeast 185-200,000 62,000 4 Bischofberge2!1970 
Yeast 150-200,000 - 4 Haeckel et al., 	1968 
Rat liver 298,300 - Tanaka et al., 	1965 
Pig liver 202,000 50,000 4 Hess et al., 	1972 
Rat muscle 250,000 - ? Tanaka et al., 	1965 
Rabbit muscle 232-242,000 - 4 Cottom et al., 	1969 
Cat muscle 240,000 - 4 Levine et al., 	1978 
Human muscle 241,000 63,000 4 Peterson et al., 	1974 
Human M2 (kidney) 206,700 50,500 4 Harkins et al., 	1977a 
Human M2 (lung) 205,000 62,000 4 Corcoran et al., 	1976 
Human erythrocyte 195,000±6,000 - 4 Blume et al., 	1971 
Human erythrocyte 205,000±5,000 - - Staal et al., 	1971 
Human erythrocyte 230,000 - - Adachi et al., 	1977 
Human erythrocyte 237,000 - - Ibsen et al., 	1971 
TABLE 1.1. Molecular weight differences in pyruvate kinase isoenzymes 
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FIGURE 1.2. 
The electrophoretic mobility of pyruvate kinase ioenzymes 
(Taken from Tanaka et al., 1971). 
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• Peptide maps of tryptic digests of types M 1 and M 2 . About 2 mg of sample were oxidized with performic acid, lyophilized. and 
i suspended in 0.2 ml of 0.2 M ammonium bicarbonate, pH 8.6, mixed with 5 l trypsin solution (2.5 mg TPCK-trypsin in 0.3 ml I 
HCI), and incubated for I h at 37°C. Then, a further 5 ul trypsin solution were added and incubation was continued for an 
itional 2 h. Chromatography was done on the vertical axis, followed by electrophoresis on the horizontal axis. (a) type M 1 ; (b) 
napping of types M 1 and M 2 ; (c) type M 2 . The spots encircled by Continuous lines were highly reproduc le in three to six 
pings, and those encircled by dotted lines were very faint or poorly reproducible. Filled circles in (a) and (c) indicate spots that 
r. and open circles in (a) and' (c) indicate common spots. 
FIGURE 1.3. 
Peptide maps for pyruvate PK—M 1 and PK—M2 (From Saheki et 
al., 1982). 
be terminal peptides and would not therefore be removed by post-
translational modification. In vitro translation experiments using 
mRNAs extracted from rat red cells and liver have shown the presence 
of tissue specific mRNAs (Marie et al., 1981), which, combined with 
the previously described genetic and biochemical evidence, has led to 
the conclusion that the PK-L and PK-R are both coded for by a single 
gene (Pk-1), which produces tissue specific mRNAs, either by 
differential transcription of exons or the differential processing of 
a single primary transcript. 
A similar situation has been shown to occur with PK-M 1 and PK-M2 . 
PK-M 1 and PK-M2 differ both kinetically (Pogson et al., 1968; 
Carbonell et al., 1973; Harkins et al., 1977) and 
electrophoretically (Imamura and Tanaka, 1972; Ibsen and Kruegar, 
1973; Marie et al., 1976). However PK-M 1 and PK-M2 cross-react 
immunologically (Harkin et al., 1977; Marie et al., 1976). In the 
mouse they have been shown to be coded for by the same structural gene 
in a mutant with decreased activity in PK-M 1 and PK-M2 , but not PK-L 
and PK-R (Johnson et al., 1981) and by an electrophoretic variant of 
PK-M 1 and PK-M2 (Peters et al., 1981). Peptide mapping showed them 
to have 61 spots in common (Fig. 1.3) (Saheki et al., 1982). By the 
use of in vitro translation, PK-M 1 and PK-M2 were also shown to be 
the products of one gene producing tissue specific mRNAs (Noguchi and 
Tanaka, 1981), presumably by a similar mechanism to the differential 
expression of PK-L and PK-R mRNAs. For historical reasons, in the 
mouse the gene that codes for PK-M 1 and PK-M2 is called Pk-3. There 
is no Pk-2 gene. 
3 
The interrelationships in mammals can be summarised as follows: 





PK-M 1 Muscle 
PK-M Kidney 
These relationships only exist, however, in mammals after birth. 
In all tissues in the foetus, the primary isoenzyme is PK-M 2 . In the 
majority of tissues except kidney, the transcription of PK-M 2 mRNA 
decreases just prior to birth (Imainura and Tanaka, 1972). The 
developmental profile for liver PK isoenzymes is shown in Figure 1.4. 
In the foetus, the Pk-1 gene is not expressed at all in the liver. 
Just prior to birth, transcription of the Pk-1 gene begins. As the 
level of Pk-1 transcription increases, the level of Pk-3 
transcription decreases until in mature liver the major isoenzyme is 
PK-L from the Pk-1 gene. Pk-3 does not cease to be transcribed 
completely but maintains a level of approximately 20% of the total PK 
activity in adult liver. If the liver is damaged or a tumour develops, 
expression of Pk-1 decreases and Pk-3 increases (Fig. 1.4). 
4 
Developmental profile of PK isoenzymes in the liver 
+ 	+ 
Birth Onset of hepatoma 
or regeneration 
FIGURE 1.4. 
The developmental profile of pyruvate kinase in the liver showing the switch from 
expression of Pk-3 to Pk-1 and the reverse during regeneration and in hepatomas. 
1.2 Structure and amino acid sequence of PK 
In all species examined, pyruvate kinase has been shown to be a 
tetrameric molecule built up of four identical subunits. Each subunit 
is a single transcriptional unit. Although there is some variation in 
molecular weight, all are in the region of 60,000 dalton (Table 1.1), 
producing a functionally active molecule in the region of 240,000 
daltons. 
As previously mentioned, pyruvate kinase is an ancient enzyme 
found ubiquitously throughout nature, and it has been shown to be 
highly conserved at both a functional and structural level. 
Amino acid sequences and structural relationships have been 
determined by a variety of biochemical and molecular techniques 
including peptide mapping (Saheki et al., 1982), X-ray 
crystallography (Levine et al., 1978; Stuart et al., 1979), amino 
acid sequencing (Johnson et al., 1979; Humble, 1980; Burke et al., 
1983; Anderson and Randell, 1985; Hoar et al., 1984), amino acid 
composition 	
I 
)o_-<orc et al., 1970) and Uie ae_6vd-,o,, of amino acid 
ccorv cD'JP 
sequences (Lon bert and Gilbert, 1983, 1985; 	 et al., 1986). 
The three dimensional structure of rat PK-M 11 as determined by X-
ray crystallography to a resolution of 2 (Stuart et al., 1979), is 
represented in Figure 1.5. Sequence homology predicts a similar 
structure for PK from other species and other isoenzymes. The 





The structure of pyruvate kinase, from cat muscle, the 
diagram has been exploded to show exon positions which 
are marked by the numbers. The dotted lines indicate intron 
positions (From Lonberg and Gilbert, 1985). 
functional molecule. From these studies it is concluded that each 
subunit of PK is divided into three domains, the central A domain, 
which compromises approximately half the total mass of the protein, 
and which is flanked by two smaller domains B and C. Domain A is a 
symmetric eight stranded /3 barrel, adjacent /3 strands are connected by 
(1' helices which form a larger cylinder of parallel helices concentric 
with the /3 barrel. The course of the polypeptide chain around the 
barrel is interrupted between the third /3 sheet and the third (Xhelix 
by the next 13 domain. The chain then completes the barrel and finishes 
with the COOH terminal C domain. The correspondence between primary 
and tertiary structure is thus A 1 -B-A2-C, with A 1 and A2 referring to 
the two components of the A domain. 
The percentage amino acid homology between the PK of yeast and 
chicken muscle PK (Fig. 1.6) has been compared (Lonberg and Gilbert, 
1983), and it has been suggested that the areas of very high homology 
may represent the ADP and PEP binding sites. Domain C appears to 
contain the mononucleotide binding fold. This structure, defined as 
one half of the dehydrogenase NAD binding domain, is common to many 
nucleotide binding proteins. 
The active sites reside between domains A and B and are highly 
conserved between species, for example rat M 1 , M2 and chicken M have 
identical sequences (Muirhead et al., 1983). Rat liver is similar 
but not identical and this difference may reflect the enzymological 
differences between L and M isoenzymes (Hiroyasu et al., 1986), and 









Comparison of the primary structures of yeast and chicken PK. The percentage homology at each residue is a weighted average over 
t 15-residue window; the weighting factor is (8 - d)/64, in which d is the distance from the center of the window. Only exact matches are scored; 
nsertions are counted as mismatches. Below the homology plot, arrows indicate the locations and lengths (in amino acid residues) of the minimum 
iumber of insertions required to maximize identities or conserved substitutions. The approximate locations of the structural domains are indicated 
Lbove the plot (see text). 
FIGURE 1.6. 
A comparison of the primary structure of yeast and chicken pyruvate kinase 
(from Lonberg and Gilbert, 1955). 
Amino acid sequence analysis has been approached in two ways, 
directly by amino acid sequencing of peptides, and indirectly by 
sequence analysis from cloned cDNA sequences of the most appropriate 
open reading frame. 
To date, direct sequencing has only produced partial amino acid 
sequences of some peptides whereas cDNA sequence analysis has produced 
complete amino acid sequence predictions for yeast PK, chick P1(-M 1 , 
rat PK-M 1 and PK-M2 and rat PK-L (Burke et al., 1983; Lonberg and 
Gilbert, 1983; Hiroyasu et al., in press; Tanaka, T., personal 
communication) (Noguchi et al., 1986). Comparison of direct and non-
direct sequencing methods has produced results in good agreement, 
although the occasional mismatch, for reasons unknown, have been 
reported (Hiroyasu, in press). Comparison of amino acid sequences from 
different species has shown domain A to be the most highly conserved 
whilst domain C is the least conserved. In all sequences so far 
studied, M type pyruvate kinase molecules have been shown to be 
shorter at the NH  terminus when compared to liver L type sequences. 
The NH  terminal amino acid in M type PKs is also'normally blocked by 
acetylation. The extra amino acid sequence in L type PKs is believed 
to constitute a regulatory domain involved in the 
phosphorylation/dephosphorylation inactivation of L PK. A cAMP binding 
site is observed (Lonberg and Gilbert, 1983; Humble, 1980). 
7 
Lys - Arg - X - X - Ser 
and 
Arg - Arg - X - Ser 
Consensus sequences of cAMP-dependent phosphorylation site. 
This extra regulatory site is believed to be necessary to prevent 
futile cycling during gluconeogenesis in the liver. The work on the 
relationship between the PK-R and PK-L isoenzymes using proteolysis 
with trypsin and subtilisin, directly contradicts this position for 
the phosphorylatable site (Simon et al., 1983). Peptide mapping and 
analysis of trypsin and subtilisin cleaved PK-R and PK-L isoenzymes 
(producing two smaller forms, PK-Lb (60,000 daltons) and PK-Lc (57,000 
daltons)), indicates cleavage is occurring at the COOH terminal with a 




L 60K Da 	 R (L' in the paper by Simon) 
3 subtilisin 	 3 trypsin 
Lc 57K Da 	 Lb 60K Da 
3 subtilisin 
Lc 57K Da 
Lc is not phosphorylated 
Evidence from peptide mapping, and the fact that the NH  terminal 
remains blocked during proteolysis, has led to the proposal that the 
8 
9 
PK-R message is extended at the 3' end producing an extra peptide at 
the COOH terminal. Proteolysis would then cleave the COOH terminal 
and eventually remove the phosphorylatable site (Fig. 1.7). 
However, as proteolysis removes all phosphorylation sites, it must 
somehow affect the site identified at the NH  terminal whilst leaving 
the NH  terminal blocked! Although rat PK-L and rat P1(-M 1 are coded 
by different genes, (Pk-1 and Pk-3 respectively), their molecular 
organisation and sequence homology is remarkably similar, evidence 
that the two genes arose via duplication and not convergent 
evolution. The overall percent homology is 63%, with some regions in 
domain A as high as 98%. 
1.3 Molecular organisation 
Several PK genes have now been cloned, yeast PK (Burke et al., 1983), 
chicken PK-M 1 (Lonberg and Gilbert, 1983), rat PK-L (Simon et al., 
1983; Noguchi et al., 1983), rat PK-M 2 (Noguchi et al., 1983) and 
rat P1(-M 1 (Tanaka, personal communication). Of these, complete 
sequencing of cDNA from mRNA has been achieved for yeast (Burke et 
al., 1983), chicken PK-M 1 (Lonberg and Gilbert, 1983) and rat PK-L 
(Hiroyasa, in press). Partial sequences have been elucidated for rat 
PK-M 1 and rat PK-M2 (Tanaka, personal communication), although for 
both of these the translated sequences have been completed allowing 
derivation of the amino acid sequence (Fig. 1.8a,b). 
It has already been shown (Section 1.1) that in rat, two genes Pk-1 
and Pk-3 code for 4 isoenzymes, each gene differentially producing 
Trypsin 
FIGURE1 T.  
The proteo1ytC cleavage of PK-R (FI<-L 1 ) to give the forms PK-L 
and FK-Lc (from Simonet al.., 198). 
Partial nucleotide sequences of rat 	and M 2-type pyruvate kinase cDNAs 
and the corresponding amino acid sequences 
MC. ACT. CCC. ATC. ATC. TCT. ACC. A11. CCC. CCI. CCT. ICC. CCA. TCT. GIG. GAG. ATC. CTC. MC. GAG 
Aan- The -Q , - Il .-lIs-Cy. The 11s0 p-P,.A1 s-Say-Mg-Say-Vat -a u.teT Lau- Lys -Q si 
ATC. ATT. MG. iT. CCC. AIC. MT. CrC. CCT. CCC. arc. AM. TTC. ItT. CAT. CCA. ACC. CAT. GAG. TAG 
MET-11 s -Lys -So r-O p-IET-Mn-VaI -N s-Arg-Lau-Aan- Ph* -So v-14 a-CL y- The-Ill a-CL u-Tyr 
121 CAT. CCA. GAG. ACT. ATC. MC . MT. CTC. 	 CAA. ACC. 	 TI 
te s-N a-C u- Thr - IIs - Lps - AanVaI - Afg- MaNaTh,C u-S.rPh.-N s-S.r-Aap- Pro- Il. 
dC. TAC. CGA. CCI. CIT. CCC. dc. CCT. CTG. CAT. ACA. MC . CCA. CCI. GAG. ATC. CCC. ACT. CCA. CrC 
Lou-Tyr -Mg- Pro- Val -At s- Val -N a-Lau-Aap- The - Lys -GI p-Pro-a u-Il .-*rg-Thr-Q p-Lau 
ATC. MC.. CCC. ACC. CCC. ACC. CCA. GAG. CTC. GAG. CTC. MC . MG. CCA. CCC. ACA. CrC. MG. Alt. ACC 
II s- Lys -O p-S.r-a pThr-M a-CL u-Vs1 -Q u- Lou- Lys - Lys -CZ y- At a The Lau Lys II a- The 
Crc. GAG. MC. CCC. TAG. ATG. GAG. MG. ICC. CAT. GAG. MG. ATC. CT;. TCC. dC. GAG. TAT. MG. MC 
Lsu-Asp-Aan-Al s-Tyr.AET-C u-Iys-Cy.AapC u-Mn-Il .-Lau-Trp-I.au-A,p-Tpr-Lys-Aan 
311 ArC. ICC. MG. CTC. CrC. GAG. CrC. OCC. AGG. MC. ATC. TAG. CrC. GAG. CAT. CCC. dc. AId. ICC. CrC 
II s-Cya-Lps-VaI v.t -a u-Vst -O p-S.r-Lys-I I .-Tyr-Val -AspMp-Q y-I.au-I I .-Ssr-Lou 
CAC. CrC. MC. GAG. MA. CCT. GCT. GAG. TAG. dIG. CrC. ACA. GM.. GIG. GM.. MT. CCI. CCC. ICC. 1rC 
C n-Vat -Lys-(;I u-t.ps-a p-N a-AspTyrt..srVal -Thr-a u-Vat -C u-Mn-a p-a y-S.v-Lau 
Id 
asi CCC. AGC. MG. .MG. CCC. CC. MG. dc. CCI. CCI. OCT. GdtGTL c*c. crc. CCr. ccr. crc. rca.. c. 
C! y.Ssr.LysLy*C2 p-Vat -Aan-Lau-Pro-Q p-N s-AL a-Vat -Asp-Lau-Pro-M s-Vat -S.c-Cu 
AZ. GAG. ATC. GAG, CAC.  CrC. MC. ITT. CCC. CrC. GAG. GAG. GAG. GIG. GAG. ATC. GIG. rrr. CCC. id  
Lys - Aap- I 1.-a n-AspLauLysPhs-a p-Vat -a u-CL n-Up-Vat Aap&.ET.VaI -Ph.-Al s-S.. 
A 
Ill TTG. Arc. CCC. MG. CCC. OCT. GAG. GIG. CAT. GAG. CIT. ACC. MG. GIG. dc. CCA. GAG. MG. CCC. MG 
Pt.-t I s-Avg-Lys-N s-AL a-Up-Vat -II s-a u-Vat -Arg-I.p..Val -Lau-a r0 u-Lp.-C p-Lp. 
MC. AIG. MG. ATC. ATC. ACC. W.. ArC. GAG. MG . CAT. C.I.A. OCT. CrC. CCC. ACC. rrr. CAT. GAG. AlT 
Mn-Il s- Lys -I Is - Il s - S.r - Lyst la-C u-A..n.III a-a u-C p-Vat -Mg.Arg.Phs-Aap-O u- Il. 
721 rrc. GAG. CCC. ACC.. CAT. CCA. ATC. ATC CIA. CCT. CCI. CCT. CW_ crc. ccc. Arr. GAG. ATT. CCC. CCA 
Le w(3 u- At a-S.r-Aap-a p- Il s- WT- Vat -N a-Avg-a y-Aap-Lau-Q p-I 1.-U u-I I s- Pro -At a 
GAG. MC. crc. ,-rc. CIA. CCI. CAC. MG. ATG. ATC. ArT. CCA. CCA. icC. MC. CCA. CCT. CCC. MG . CCA 
a u- I.yAVSI - Ph* - Law AL a-CL n- Lys - MT- lET-I Is-CL p-Mg..Cys-Aan-Arg-N a-C y- Lys -Pro 
III CIC. ATC. ICC. CCC. ACC. GAG. ArC. arc. GAG. ACC. ATC. ATC. MG. MG. CCA. CCC. CCC. ACC. CCI. CCI 
Vat -II s-Cpa-Al s-mr-a n-WT-t.au-C u-S.r-ACT-I I a-Lys.Lya -Pro-Arg-Pro-Thr-ArgNa 
CM. CCC. ACT. GAG. dc. CCG. MT. CCA. CrC. CIA. CAT. CCA. CCT. GAG. ICC. ATC. ATG. crc. TCC. CCA 
C u-C p- SarUp.VaI -N s.Mn.AL a-Vat -Lau-Ap-CL y- At s.Aap-Cps-I I .-lEI-Lau-Ssr-CI p 
 5 
ill CM.. ACA. CCC. MA. CCC. GAd. TAG. CCT. CTC. GAG. CCI. CIT. CCC. ATG. CAC. CAC. CTC. AT;. CCC. cc 
Q u-Thr- At a-I.ps-C p-A p.Tpr-Pro.I.su.0 u-AL a-Val -Mg-lET-C n-I' .-I.au-t Is-Na-Avg 
ATA. CCI. CrA 
I Its-Ma-Avg 
. a • s •.s S •• • S • 5•5• 5•5a••a.S 
CAG. CCA. GAG. CCI. CCC. ATC. TAG. GAG. rrc. GAG. TTA. TTC. GAG. GM .. dC. CCC. CCC. GIG. CCC. CCC 
C u- Al s -OuALaM s-IIs- Tyr .45 a-Lsu-a n-I.su-PN.-C ­Cl u-Lsu-Arg-Avg-Lau-M a-Pro 
GAG. CCT. GAG. GCA. ccc. crc. rrc. GAG. CCC. CTd. Crc. 1-rI. C.I.A. GAG. crr. ccc. cc.a. ccc. icc. ACT 
I CL u- Al a - C u-AL a-N s-Vol -Ph.-b5 s.Mg-Lau-Lsu-Phs-Q u-a u- Lou- AJ s-Mg-N s- See -See 
M. 	 a. 	 ..s • S... 	S 	• .. 	 S 55 5 5 1011 ArT. ACC. .ACC. GAG. CCC. ACA. CM.. CCI. CCC. CCC. GIG. CCI. CCC. GIG. GAG. CCC. ICC. TTC. MG . ICC 
II .- The - See -Ai-Pro-Thr-C u-Al a-AL a-AL a-Vat -CL y- AS .-Val -C u-AL a-Sar-Ph.-Lys-Cys 
u CM. ICC. ACA. GAG. CCC. CTG. GAG. CCC. ATG. C= AIG. CCC. .ICC. CTc. GAG. CCC. ICr. TAT. MA . TCT 
I0 n- See - The -Mp-Pro-t.au-CL u-N a-SET-N s-SET-CL y- See -Val -a u-N a-S.r- Tyr- Lys -Cy$ 
55555 •a SS5 S • a 0 	5 
TCC. ACT. CCC. CCC. ATT. ATC. GIG. CTC. ACC. MC . ICr. CCC. ACC. ACT. OCT. CAC. CM . CTC. CCC. CCC 
Cpa-Say-C y- At a - Its - Its - Vat -L.u- The -I.ps- See -Q y.M.g.Sar-N s-14 a-CL n-Vat MaAfg 
IrA. CCA. CCA. OCT. TTG. AlA. Cr1. CrC. ACC. GAG. ICC 
I I.au-AL a-AL a-N s- Low t Is-Vat - Low The .0 u-Ssr 
1O I TAG. CCC. CCA. ACG. CCI. CCI. Alt. AlT. CCI. did. .ACA. CCC. MT. CCC. CAC. ACA. CCC. CCC. GAG. CCC 
Tye.Avg-Pro-Arg-M s-Pro-I Is- Its-AL a- Val -The-Avg-Mn-Pro-a n-mr-Ma-Avg-an-Ma 
CAT. CrC. TAG. CCT. CCC. ATC. T7C. CCT. crc. CrC. ItT. MG. CAT. CCC. CIA. CTC. CAT. CCC. TCC. CCT 
II s.Lem-Tpr.Arg-a p-Il a-Pha-Pre-VsI -Lau-Cys-Lys-Asp-N a-Vat -I.. u-U p-N a-Tv p-N a 
1321 GAG. GAG. CIT. CAT. CIT. CCI. GIG. MC. TIC. CCC. ATC. MT. CIT. CCC. MG. CCC. CCA. CCC. TIC. TIC 
CL u-Up-Vat -Asp-LaoMg-Val - Un-Lou-Al a-SET-Am-Vat -Cl y-Lys-N a-Avg-a p-Phs-Phs 
MC. MG. CCA. CAT. GIG. GIG. ATT. GIG. Cit. ACT. CCA. ICC. CCC. CCI. CCC. itT. CCC. TIC. ACC. MC  
Lys -I.ya -O p-Asp-Vat -Val -11 *-Val -I.au-The-CI y-Tvp.Arg-Pro-C p-Ssv-Q p-Phs-ThrAsn 
Joel ACC. ATC. CCI. CIA. GIG. CCI. CIA. CCA ICATGATCCTCICC.*GCTTCTCITCTACCCCCTCICCCITCCCCICC 
Thy-SET-Mg-Vat -Val -Pro- Val -Pro 
1313 CCIAICCIATCCATTACCCCACCAAGCTTCTAGIGCICACICICCCCCATACTCTCCGCCTGCTCCCCTCCCAGACGAG 
CM.AAATTAATCCCTCIGMACATCCAATAGAGCCCACCTATITTTCATcCCCCTACTTCAGCCACCCGIGAGCA 
lilt ATGGACCATTCCM.acccIcrcAcrrTArcAc.a.G.I-ACGGCACCATrAI d,tTCTCTIcTrTCCTCCTCTACM.AC1TIT 
CC.&CACAATTCCCACCCCTCCCCTCC.AATCACCACACACCAA.CM .CACAGCCIGCGCCCCCACCCTTCCCAT G 
1121 AC.rrrTCCCCCTCTCCCTCACrTCCTT .TCCCAACACCTTTCCCCICTCTCCICCICCACICCACIGGIGICCCICGACA 
ICTCCACTCTCCACCTCCIACTCTCCACCGTCTCGACCCCTCITCCIATACTCCCCACCTCAATCTCAATM.ACACCA 
Ill? CCCCA.AC1A1 01 
Figure 1.8a. 
Partial nucleotide sequences of Rat PK-M 1 and PK-M2 and 
their amino acid sequences (T. Tanaka, personal communication). 
Complete Nucleotide Sequence* of K. L ?K cDNA 




CTCCACMGCMATGUTGCCTICTTCCACCCAITTACAGA CTCA.AGTTTCATCAAATTCTAGMCCUCGTAGCACC -I 
I AIG. GM.. COG. CCA. CCC. CCA. TA 	CGA. CCI. CCC. ..T. crc. CCI. CAA. Crc. ACC. GAG. GAG. crc 
I 	i.0..0 y.Pre.AIi.0 y.Ty.'.Leu.A.'g.A'g.Ns..Vol .N..On.L.u.Th,.On.Ou.Lou 
CCC. ACT. CCC. Tic. TIC. GAG. GAG. GAG. CAA. CIG. CCC. CCA. CCI. Arc. ccc. GAG. ftcC. Tic. Crc. CM. 
ay.Th.M..Ph.. Ph* .0n.0n.Qn.0n. Lau. Pro. M..N..SMl .Na. Asp. The. Pbs. Lou. Ou 
Ill CAC. crc. icc. err. dc. CAT. ATM GAG. 'rCA. GAG. OCT. GIG. CCI. CCI. OCT. ft. ACC. AGC. AIC. AlT 
01 14 ..Lau.C1,. Low. Lou. Asp. ll..AaP. See. 0fl.Pre.Vll .Ma.Na.Mg.S.r.Thr.S..'.II..II. 
GCC. ACC. ATT. CCC. CCA. CGA. ICC. OGM Id. CrC. GAG. CCC. CIC. MC. GAG. AIC. ATC. MA. CCA. CCC 
AI.. The. ll..0 y.Pro.N s.S.r.Mg.S.r.Val . Asp. A..g. Lau. Ly..0u.t .II..Ly,.Ms.0 y 
III AIG. MC. ArT. GCA. OA. CTC. MC. TIC. ICC. CAT. CCC. ICC. CAT. GAG. TAG, CAT. GC.. GM.. TO 
Al 
 
A06e.AAn.II...*J..A .l..u..Aan.Pt.s.S.r.IIi.Oy.Sar.14s.Ou.Tyr.0I s.M..Ou.S.r.11. 
- CCC. MC. ATC. CCC. GAG. GCA. ACT. GAG. ACT. ITT. CCA. ACC. ICC. CCA. CIC. AGC. TAG. ACA. CCI. GIG 
N ..A*n11 s.M'g.O u. At .. The. Q u.S.r.Phs.N .. The. 3.r. Pro. Lou. S.r. Tyr. A.'g. Pro. WI 
361 CCC. ArC. Ccc. crc. GAG. ACC. MG. CCA. CCI. GAG. ATA. CCA. ACt. CCA. crc. Tic. cc. 0CM CCT. Ccc 
III AIa.Il..N.. Lou. Aip. The. Lys. 0 V. Pro. 0u.Ile.A.Q. The. 0y. Val . Low. On.0y.ay.Pro 
GAG. ICC. GAG. GIG. CM.. ATT. GIG. A.AG. CCC. ICA. GAG, GTC. GIG. CTG. ACG. CrC. GAG. CCC. MG . TiC 
CI u.S...Q u.VaI .0 u. IIs.Val . Lys. 0 y. See. Gn.VsI .L.u.VaI . The. Val .Np. Pro. Lys. Pha 
lOt C_AC. ACA. ACC. OCT. CAT. GCA. MG. ACA. GIG. ICC. CrC. GAG. TAG. GAG. MT. ATC. ACC. CCC. CrC. CIT 
III On. The. Arg.O y.Asp.A1.. Lye. The. Val .Irp.WI .Mp. Tyr. II ..Mn.II.. The. A.'g.Vat .Wt 
CCA. CrC. ccc. ccc. CCC. ArC. TAG. All. GAG. GAG. COM  dIG. ATC. ICC. TTA, Cit. CiA. GAG. AM., AIC 
Al i.WI .0 y.0 1.Arg.Il..Tyr.II..MP.Aip.0 y.L.u.11s.S.,.L.u.Wl .V.I .0 fl.I.yt.IIs 
iii GM CCA. GAG. W.A. GIG. CTG. .ACA. GM.. GiG. GAG. GAG. CCI. CCI. ATC, TIC. GCC. . ACC. MG. CCI 
III 0 y.Pr..0u.0 y.l..u.WI .Th.'.Ou.Val .0u.14.0y.0y.lI..L.u.0y.5ar.Arg.Lys.0y 
GIG. MC. TIC. CCA. MC. ACT. GAG. GIG. GAG. CrC. CCC. CCC. CrC. ICr. GAG. CAA, GAG. CIT. Tic. CAT 
VII .Aan.L.u. Pru.Mn.Thr .0 u.V.I .Asp. Lou. P,.0 y. Low. S.r.0 ...0 ...Mp.L.u. L.u.A.p 
731 CrC. CCC. TIC. CCC. GIG. GAG. CAT. MT. GIG. GAG. ATC. AIC. ITT. CCC. IOC. ITT. GiG. a, AM.. CCC 
ill Lsu.A,g.Pt..0 y.Wl .On. III ..Mn.VI0. Asp. lI..lI..Plo..fla. See. Phs.WI .M'g. Lys. M. 
ACT. GAG. GIG. TTA. CCA. GIC.. CAT, OCM GIG. OOM CCA. CAA. WA. GAG. MC. ATM AM.. All. ArC 
S.r.Mp.V.l . L.u.Ai a.WI .Arg.AAp.N .. Lau. Q y.Pv..0 u.Q v.0 n.An.lI..Lys.II..IIs 
SAl .0CC. MA. ATC, GAG. MG. CAT. GAA, CCC. GIG. MG . MG. iTT. CAT. GM. ATT. CIA. GM. GIG. ACC. CAT 
Ill S.,. Lys. Ila.0u.An.l4s.0u.0y.VII . Lys. Lys. Phs.Mp.Ou.lI..Lau.Ou.Wl . See. Mp 
CCC. ATC. Arc. GIG. GCA. 	. CCI. GAG. GIG. CCC. AIr. GAG. ATC. CCI. GCC, GAG. MG. GTT. TIC. TIC 
O y.11.. Its t.Vll .N..l.g.O y.Asp.L4u.0 y.11s.Ou.IIs. Pro. N a. 0 u. Lys. V.l .Phe.Lou 
Ill CCI. GAG. MG . ATC. Alt. AlT. CCA. CCC. TCC. MG . dIG. CCC OCC. MG. OCT. CrC. cr1. itT. CCC, ACA 
331 N..Qn. Lys. kin S.&t.II..0 y.Ag.Cys.Aon.L.u.N..0y. Lys. Pro. V.l .V.l .Cyl.Na.The 
GAG. ArC. dIG. GAG. AGC. AIG. ATG. ACT. MG. OCT. CCA. CCA. ACT. CCG. OOM GAG. ACA. ACC. CAT. GIG 
O n.W.t . Lou. 0 u. See. 0, .11 a. The. Lys. AlS.M'g. Pro. The. A,g.N ..0 u. The. See. A.Val 
loll CCC, MT. CCC. GIG. CIG. CAT. GGM OCT. GAG. IGI. ArC. ArC. CTC. ICC. CCA. GAG. ACC. CCC, MG. 
340 N l.A.n.Al..V.I .L.u.Aap.Q y.M..Mp.Cys.Ill.&t. Low. S.r.0y.0 is. The. M.. Lys. 0 v 
ACT. TIT. CCI. GIG. GM .. OCT. CIA. Arc. ArC. CM.. CAT. GM ATT. CCC. 0. GAG. CCI. GAG. cm. CCT 
See. Ph.. Pro. Val .Ou.Ms.Val . blot .3t.0n.l4 ..M..II...OJ..M'g.Ou.N..Ou.M ..M. 
1201 GIG. TAG. GAG. CCC. CAG. TIC. ITT. GAG. GAG. CIA. OGC. 	, CCA. ODG. 	, GIG. AGC. OCT. GAG. CCA 
001 VII . Tyr. I1 9.A.g.0 n. Lau. Pb..0u.0u.Lu.Arg.A.N ..M.. Pro. Lou. See. Mg.A.p.Pr. 
ACT. GAG. GIG. ACT. 	, Arr. GCA. CCC. CTG. GAG. CCI. ICC. TIC. MG. ICC. IGI. CCA. CCA. CCC. AIC 
The. Ou.Val . The. N l.11..O y.N..WI .0ll.Ns. See. P1.s. Lys. Cvs.Cyi.Ms.N..Ai 1.11. 
0320 AIC. GIG. CTC. ACG. AAG. IIC'T. CCC. Ccl. TCA. CCC. GAG. CII. CIA, ICr. CM., TAG. CCA. OCT. CCC. CCC 
Ill lI..VlI . Lou. The. Lys. The. 0y.A,g.S.,.Ns.0n.Lau. Low. See. On. Tyr. AfQ. Pro. A9.Ma 
GCT. CrC. ATT. CCI. GIG. ACT. CCA. TC1'. CCC. GAG. OCT. CCC. CCA. GAG. GTC. COG. GIG. ICC. CCI.. fCA 
M..Val .11..N..Val .Thr.M'g.S.r.Ml.On.Ms.Na.A.'g.On.Vol .04 ..L.u.5.r.Arg.J y 
1101 GIG. TIC. CCC. TIC. GIG. IAC. Ccl. GAG. CCI. CCA. GAG. CCC. Aid. ICC. CCA. CAT. CAT. GIG. CAT. CCA 
III VaI.PM. Pro. Lau. Low. Tyr. A,.0U. Pro. Pro. 0U.N..IlS.TrP.Nl.MP.MP.VII .A.p.Arg 
ACC. CrC. CM. ITT. CCC. ATT. CM., ACT. CCA. MG. GIG. CCI. CCI. TIC. CIC. OCT. GIG. CCI. CAT. GIG 
M'9.V.l .0 n.Phs.O V.111.0 0I.S..'.O p. Lys. Lou. Arg.0 y.PM. Low. Arg.Wl .0 y.Asp.Lou 
III GIG. ATT. GIG. GIG. ACA. CCI. ICC, 	. CCI. CCC. TCI. GOM TAT. .0CC. .0.0G. Arc. ATG. CCC. GIG. CTG 
$30 Val. ll..Val .V.l . The. Gy.T,p.A .P,o.0y.S.r.0y.Tyr.T.A.n.Il..3(.Ag.Wl .L.o. 







The complete nucleotide sequence of Rat PK-L cDNA 
(T. Tanaka, Personal communication). 
two mRNAs (Marie et al., 1981; Noguchi and Tanaka, 1981). The 
molecular organisation of these genes is thus very interesting in 
relation to the differential control of mRNA expression. When 
sequences of rat PK-M 1 and rat PK-M2 are compared they show complete 
homology except for the region 99-143 from the COOH terminal; in this 
region homology breaks down (Tanaka, personal communication) (Noguchi 
et al., 1986). The results indicate that rat PK-M 1 and rat PK-M2 
share the majority of exons, with each mRNA containing a unique exon 
coding for the aa 99-143 from the COOH terminal (Fig. 1.9). This 
mechanism, often referred to as exon shuffling, is represented in 
Figure 1.10 and has been shown to be present in several systems where 
more than one protein is derived from a single gene. Other examples 
include alternative splicing of the A-crystallin gene in mice (King 
and Piati gorsky, 1983), myosin light chains 1 and 3 (Periasamyet 
al., 1984) and(1-amylase (Hagenbuchle et al., 1981). The different 
mRNAs can be derived either by differential transcription or 
processing of a primary transcript. To date, non-translated sequences 
which may be involved in this regulation have not been identified. A 
further complication arises after the selection of a mRNA for a 
specific isoenzyme, as multiple forms of the specific mRNA appear to 
be present. Cloning of rat PK-L produced two mPNA species of 3.4 Kb 
and 2.0 Kb (Simon et al., 1983). Similarly, analysis of PK-R mRNA5 
(Kahn et al., 1986) showed 6 possible mRNAs differing in the length 
of the 5' and 3' untranslated regions (Fig. 1.10). 
The longest of these mRNA's contain the concensus sequence "ID" 
(Sutcliffe et al., 1982 and 1984) which was proposed as a brain 
10 
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FIGURE 1.9. 
The exon arrangement in PK-M 1 and PK-M2 . The blank exon is excluded depen1ing upon which protein, 















The multiple mRNAs determined for Pk-L expression in the liver. They all have 
the same coding sequence but differ at the 5' and 3' non-translated ends. ID is 
the 82 bp consensus sequence described by Sutcliffe and Milner (Review, 1984). 
11 
specific identifier sequence in mice. This 82 bp sequence has, 
however, been found elsewhere in other species, and though it may have 
a regulatory role, that is, at present, not known. 
Another feature of the 3' non-translated region which is of 
interest is the apparent lack of the concensus sequence AAUAAA, the 
polyadenlyation binding site. Of sequences looked at so far, only 
chicken PK-M 1 has this sequence, though all the mRNA5 are 
polyadenylated. 
Rat PK-L sequences can be compared to PK-M 1 and PK-M2 . Total 
percent homology is 70%. 5' to the excluded exon however, homology is 
very high. This region is equivalent to domains A and B, the most 
highly conserved regions as described in Section 1.1 3' to the excluded 
exon, the coding sequence is the same length but with decreased 
homology. The lowest percent homology occurs in the M 1 /M2 excluded 
exon region. Thus L also has only one exon in that region or the 
sequences could not line up. This poses a problem when considering 
PK-R. It has been shown that the major difference between PK-R and 
PK-L is at the COOH terminal (Simon et al., 1983) and not 
internally. Does PK-R therefore have the same exon as PK-L, differing 
only in an extension of the 3' coding region? 
Genomic DNA has been sequenced for chicken PK-M 1 (Lonberg and 
Gilbert, 1985), allowing the intron/exon structure to be determined. 
The gene is divided into at least 11 exons, 10 of which cover the 
coding region. These are distributed evenly over 13.6 Kb of 
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chromosomal sequence. These exons have been related to protein 
secondary and tertiary structures (Fig. 1.11). The excluded exon of 
the PK-M 1 /M2 system appears to be exon 8 at the N}i 2 terminal side of 
domain C (Lonberg and Gilbert, 1985). The exon for M has been shown 
to be 5' and next to the exon Eor M 2 (Tanaka, personal communication). 
One would therefore expect rat genomic DNA to contain an extra exon 
(8b) and to have a genomic structure as follows:- Exon 1-7 common, 8a - 
M 1 only, 8b - M2 only, 9-10 common. Thus the structure of rat genomic 
Pk-3 DNA is awaited with interest. The exon arrangement can be 
compared with protein structure (Fig. 1.5). The exons do not appear to 
be randomly distributed and all are of a similar size (153 + 47bp), 
and exon boundaries appear to fall between discrete regions of 
secondary structure. Study of such phenomena is of particular 
importance in studying the evolution of families of enzymes such as 
PK. For example cDNA from yeast and chicken is 48% homologous, yet 
yeast has no introns (genomic size 1.5 Kb), whilst chicken has at 
least 11 introns (genomic size 13.5 Kb). The question to be answered 
is: - Did introns evolve in higher species or have lower eukaryotes 
and prokaryotes lost their introns (Gilbert, 1985; Lonberg and 
Gilbert, 1985)? 
1.4 Regulation of pyruvate kinase 
Regulation of pyruvate kinase involves two levels of controls which 
will be considered separately. The first and most well characterised 
is the regulation of pyruvate kinase activity. The second and little 
understood level of regulation is the differential expression of PK in 
both a temporal and tissue specific manner. This level of control 
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Structural Features of P1< 
The position of turns made by the polypeptide chain was determined by drawing least square lines through the a-carbon positions on either side 
of a residue, and calculating the cosine of the angle made by these two lines. At each residue the calculation was repeated including the central 
o carbon and two a carbons on each side, then three, etc., out to ten a carbons on each side. 9 defined as the minimum value of the cosine at 
each residue, is plotted above; peaks indicate the positions of turns. This function corresponds fairly well to subjective assignments of turn residues. 
}-'wever, certain structural features of the protein are missed; for example, the elbow at residue 277 
is not identified by the 9 function. The locations of the three structural domains are indicated above the plot (A, and A z refer to i:t twe 
components of the A domain); a helices and p sheets below. In the absence of coordinates for backbone carbonyl, oxygens, we have assigned 
a-helix and p-sheet residues on the basis of visual inspection of the *-carbon model. Assignments based on more objective criteria may shift the 
positions of secondary structural elements. No secondary structure assignments have been made for domain B because of the ill-defined nature 
of the electron-density map for this region The intron positions are marked by dashed lines. Amino 
acid residues that correspond to or abut introns are indicated below. Dashed lines interrupt amino acids at positions that reflect the intron positions 
v.ithin cnrtnns 
FIGURE 1.11. 
The relationship between the primary and secondary structure of pyruvate kinase and intron/exon 
boundaries (From Lonberg and Gilbert, 1985). 
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involves the selective switching on/off of either Pk-1 or Pk-3 
and the selective transcription/processing of nuclear RNA to produce 
a tissue specific mRNA. 
1.4.1 Activity 
The control of glycolysis is important in tissues and unicellular 
organisms which are also capable of gluconeogenesis, e.g. yeast, E. 
coli, fungi, liver and kidney cortex. The ratio between 
gluconeogenesis and glycolysis must be controlled to prevent futile 
cycling of metabolites. This is partly achieved by control of the 
three glycolytic enzymes which, under physiological conditions, can be 
said to be "irreversible". These are pyruvate kinase, hexokinase and 
phosphofructokinase. The level of PK also controls the fate of PEP 
into one of two pathways, either into fatty acid synthesis via PI(, or 
glycogen synthesis via enolase. The ratio of the two enzymes decides 
the metabolic fate of PEP (Krebs and Eggleston, 196,). Thus, because 
of the importance of control in the liver, the regulation of liver PK 
has been most extensively studied of all the PK isoenzymes and will be 
discussed first. 
Changes in the levels of PK-L during starvation and refeeding were 
first noted over 20 years ago (Krebs and Eggleston, 1964) and have been 
followed up in many studies. 
It was first noted that fasting caused a decrease in the specific 
activity of PK and that there was then a large increase on refeeding 
(Krebs and Eggleston, 1964; Tanaka, 1965). A similar effect was also 
seen for glucose-6-phosphate dehydrogenase (Weber, 1968) but not for 
glucokinase, hexokinase or fructose-1-6-diphosphate (Krebs and 
Eggleston, 1965). It was also shown that the newly synthesised PK had 
a decreased specific activity (Kohl and Cottam, 1976), which could be 
explained if newly synthesised monomers were combining with 
deactivated monomers to form heterotetramers. 
Changes in protein synthesis were measured using an in vitro 
translation system derived from rabbit reticulocyte lysate (RRL), by 
measuring the incorporation of 35S (Cladras and Cottam, 1980g. The 
Vmax of PK was also shown to increase in high carbohydrate diets which 
coincided with increased lipogenesis and dephosphorylation (Hopkirk 
and Bloxam, 1979, 1980). The nutritional status of the body is 
directly related to the hormone levels of insulin and glucagon. The 
effects of insulin and glucagon have been studied by several groups. 
Diabetic animals have a decreased PK specific activity which can 
be restored to normal levels by insulin (Weber et al., 1965; Tanaka 
et al., 1967; Johnson and Veneziale, 1980). The opposite effect is 
seen with glucagon. Specific activity of PK decreases whilst 
gluconeogenesis increases (Exton and Park, 1969; Miyanaga et al., 
1982). This is matched by an increased incorporation of 32p (Ishabashi 
and Cottam, 1978; Johnnd Veneziale, 1980). The response to glucagon 
had already been shown to be mediated by cAMP (Tanaka et al., 
1967), which also increases gluconeogenesis (Exton and Park, 1969), 
indicating deactivation by cAMP mediated phosphorylation of PK. This 
phosphorylation has been shown to be reversible under certain 
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physiological conditions by a phosphoprotein phosphatase (Titanji, 
1977). 
Thus two different control mechanisms affect the specific activity 
of PK. These are deactivation by phosphorylation and alteration in PX 
concentration. With the cl9ning of the cDNA for PK-L measurements of 
PK-L mRNA levels can be directly made. The amount of PK-L mRNA has 
been shown to increase in rats on a high carbohydrate diet (Noguchi 
et al., 1983), using dot blot hybridization. In diabetic mice the 
amount of mPNA is decreased (Noguchi et al., 1982, 1983). Insulin 
has been shown to return mRNA levels to normal (Noguchi et al., 
1982, 1983). The mRNA level alterations are matched by the levels of 
translatable mRNA, as revealed using in vitro translation in rabbit 
reticulocyte lysate. The increase induced by insulin is inhibited by 
glucagon and cyclohexamide (Noguchi et al., in press). 
The fact that the insulin effect is inhibited by cyclohexamide (a 
protein synthesis inhibitor), implies that the transcription increase 
may be mediated via another protein. The insulin effect is very rapid 
and is associated with a large build up of nuclear RNA species 
(Noguchi et al., in press). 
A second PK-L effector which has been shown to affect mRNA levels 
is fructose, in which an increase in nuclear RNA species is also 
observed (Noguchi et al., in press; Inoue et al., 1984). The 
resulting increase in mRNA is proportional to the increase in 
translatable mRNA. However, incorporation experiments indicate no 
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increase in transcription (Noguchi et al., in press), indicating a 
stabilizing role on nuclear RNA for fructose. 
Other control mechanisms for liver PK include the allosteric 
activation by f ructose- 1, 6-diphosphate (FDP). When FDP is not present 
PK-L undergoes hyperbolic kinetics. In the presence of FDP the 
kinetics become sigmoidal, thus FDP activation is particularly 
important at low levels of PEP. ATP acts on PK-L by direct feedback 
inhibition (Tanaka et al., 1967), but the effect is altered by ADP 
levels and the critical factor appears to be the ATP/ADP ratio. 
Stereospecific inhibition of PK-L by L-alanine has also been observed 
(Carbonell et al., 1973). Finally, free fatty acid (Weber and 
Convery, 1968) and acetyl-CoA (Seubert et al., 1968) also have an 
inhibitory effect, but this is irreversible and believed to be non-
specific (Pande and Mead, 1968). Although a lot is known about the 
regulation of PK-L isoenzyme, the regulation of other isoenzymes is not 
as well understood. 
L and D alanine inhibit PK-M 1 in rat muscle and rat brain and 
phenylalanine in rat brain cortex (Weber, 1968). Muscle PK-M 1 is also 
allosterically inhibited by ATP (Jimenze et al., 1970) and is 
affected by the hormones oestrodiol and testosterone. Castration 
decreases heart PK-M 1 which is reversed by the addition of 
testosterone. Testosterone also increases muscle PK-M 1 in 
ovariectomised females. Oestradiol increases heart PK-M 1 and also 
muscle PK-M 1 in old males and castrated females (Chains and Kanungo, 
1978). 
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Further control of heart PK-M 1 occurs during the utilization of 
fatty acids when glycolysis is directly inhibited by free fatty acids 
(Tsutsumi and Tanaka, 1969). Finally, regulation of erythrocyte 
pyruvate kinase, PK-R, has been shown to be calcium-calmodulin 
dependent (Nakashima et al., 1982). Incubating red blood cells with 
Cad 2 and the calcium ionophore A23187 resulted in phosphorylation of 
PK-R. The phosphorylation was inhibited by calmodulin inhibitors. 
1.4.2. Control of isoenzyme expression 
As described previously in 1.1 and 1.2, pyruvate kinase is coded for 
by two genes Pk-1 and Pk-3 each of which can produce two mRNAs, 
each for a specific isoenzyme. Transcription of the genes and the 
particular mRNA is controlled both temporally and tissue specifically. 
Thus, apart from the structural genes, there must be several 
regulatory genes/sequences. These can be categorised into temporal 
genes, affecting the switching on and off of genes during development 
of the foetus, and tissue specific genes which are involved in 
switching either Pk-1 or Pk-3 and controlling the differential 
transcription/processing of the selected gene to give the final 
appropriate isoenzyme. 
The silencing of one or other of the PK genes is not irreversible, 
as can be seen from the compensatory production of PK-M 2 from Pk-3 
in erythrocytes in patients suffering from PK deficiency (Imainura et 
al., 1973; Miwa et al., 1975; Black et al., 1979). Under normal 
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conditions Pk-3 is switched off and Pk-1 is the only active gene. 
Pk-3 is also switched on in liver during liver regeneration 
following partial hepatectomy (Tanaka et al., 1967) and in 
developing hepatomas (Ibsen, 1977). Cultured hepatocytes also show the 
same phenomenon after 5 days in culture (Walker et al., 1972). 
Injection of cell free tumour supernatant also switches on PK-M 2 , and a 
PK-M2 stimulating factor has been isolated (Ibsen et al., 1975, 
1977). 
Gene complexes which contain both structural and regulatory genes 
have been identified for several enzymes, but to date no complex has 
been identified for PK. Control of gene expression will be discussed 
in detail in Chapter 2. 
1.5 The evolutionary relationship between the isoenzymes of 
pyruvate kinase 
Pyruvate kinase is an ancient enzyme and found throughout nature. 
Parts of the enzyme are highly conserved, especially in domain A, and 
even in such widely spaced phylla as fungi (yeast) and mammals (rat), 
the sequence homology at both amino acid and CDNA level is 40-50%. The 
major differences which occur are in the distribution of the 
isoenzymes, mammals having four distinct isoenzymes coded for by two 
genes, whilst yeast has one isoenzyme coded only, presumably, by one 
gene. Two questions arise. Firstly, when did the differential 
expression of two mRNAs from one gene occur, and secondly, at what 
point in evolution did a two gene system evolve? As mentioned 
previously, prokaryotes and lower eukaryotes contain only one 
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isoenzyme of PK. In higher organisms variation begins to arise. 
Turtles have two isoenzymes of PK similar kinetically to PK-M 1 and 
PK-L of mammals (Kornecki-Gerrity and Penney, 1974a,b). However, 
although the liver of PK of turtles is kinetically, (i.e. 
allosterically) activated by FDP, like PK-L, there is no direct evidence 
to support it being structurally like PK-L or being the product of a 
second gene. The kinetics may have evolved in a PK-M 1 type molecule to 
cover the requirements of the liver environment. 
Frog PK on the other hand has three isoenzymes, one of which (the 
liver) is immunologically distinct from the others (Schloen et al., 
1974). Avian PKs, as represented by the chicken, do not appear to 
have a separate liver type PK but only PK-M 1 /M2 types (Strandholm et 
al., 1975). 
In mammals it is known that two genes code for PK 1(Pk_1 and Pk-3.r OuSe) 
Pk-3 has been mapped to mouse chromosome 9 (Peters et al., 193 1 ) 
and Pk-1 has been shown to be unlinked to it (Moore, 1981). The 
similar molecular organisation and sequence homology implies that the 
two genes arose from duplication and not convergent evolution. If this 
is so, when did the duplication arise? The evidence from the 
distribution of isoenzymes appears to be, at first, contradictory. If 
duplication occurred before separation of the lines leading to frogs 
and chickens, why do chickens not have a second gene producing an L 
type molecule? If the duplication occurred after the split, from where 
has the frog L type enzyme evolved? There is no clear answer to this 
problem, but there is some slight evidence for a PK pseudogene in 
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chicken (Lonberg and Gilbert, 1985). Could this be a duplication which 
instead of evolving into an L type enzyme has been silenced? 
Another interesting evolutionary question is posed when genomic 
DNA is compared to cDNA. Yeast and chicken cDNA is 48% homologous, yet 
the yeast genomic DNA is 1.5 Kb in length (Burke et al., 1983), 
whilst the chicken genomic DNA is 13.8 Kb and contains at least 11 
introns (Lonberg and Gilbert, 1983). Thus, have introns evolved and 
been inserted into the genome, or have prokaryotes and lower 
eukaryotes streamlined their genomes to remove introns which 
originally existed? The non-random spacing of introns, (at structural 
and functional boundaries), supports the hypothesis that genes are 
built up from small modules joined by introns which have been removed 
by the lower eukaryotes and prokaryotes (Lonberg and Gilbert, 1985; 
Gilbert, 1985). Further analysis of PK isoenzyTnes and comparison with 
functionally similar enzymes may help to clarify this point. 
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INTRODUCTION PART 2 - THE CONTROL OF GENE EXPRESSION 
Nowhere, not even in the simplest of genetic systems, are all genes 
expressed at the same time. In prokaryotes and unicellular eukaryotes, 
genes are expressed in accordance with the phase of the cell cycle, or 
in response to environmental changes. In such simple systems, a wide 
variety of regulatory elements and genes have been described, as have 
the many ways in which regulation is affected. Regulation can be 
mediated by both cis and trans acting factors, repressors and 
inducers. How much more complex then must be the control mechanisms 
involved in multicellular organisms? Development and differentiation 
require a different set of regulatory controls to be operating in each 
cell lineage, which must then be maintained under a variety of 
environmental influences, which themselves require different genes to 
be regulated in different tissues. Thus the regulated expression of 
structurally distinct, tissue specific and developmentally regulated 
proteins is an essential stage in cellular differentiation. 
Differentiated cells possess a remarkable capacity for the 
selective expression of specific genes. A single gene may code for a 
large percent of the total protein of one cell and yet be undetectable 
in another, and then be switched on as physiological conditions change. 
With the wide application of recombinant DNA technology, progress 
is at last being made in the little understood molecular mechanisms 
which control gene expression. Before discussing some of the 
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mechanisms involved in gene expression it is necessary to describe the 
types of genes found in higher eukaryotes as follows. 
2.1 Categories of genes (Paigen, 1979 review) 
2.1.1. Structural genes 
Structural genes are usually defined as segments of DNA which code for 
the amino acid sequence of the primary translation product, although 
they may be modified to form a functional protein molecule. This 
definition excludes genes whose products are involved in regulating 
the expression of other genes, or processing their products. 
2.1.2. Processing genes 
This category includes genes whose products are involved in post-
translational modification and can be further sub-categorised. 
Modification genes 
These are genes whose products have the ability to modify covalently a 
primary protein sequence, and may include proteolytic enzymes or 
enzymes involved in acetylation, glycosylation etcetera. 
Architectural genes 
This group includes genes which determine the proteins required for 
the correct secretion or intracellular location of a protein. 
(C) organellar genes 
These genes affect the organisation, assembly or functioning of entire 
organelles. 
(d) Turnover genes 
only one mutation in a gene of this type has been reported and this 
affects the rate of catalase turnover in liver. Genes affecting 
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turnover are extremely important to the cell as they directly affect 
enzyme concentration. 
2.1.3. Regulatory genes 
Regulatory genes modulate the activity of structural genes, and exclude 
processing genes and temporal genes. They can be divided into three 
categories. 
Systemic regulatory genes 
Mutations in these genes change the rate of enzyme synthesis 
throughout the organism and at all stages of development. A variety of 
mechanisms can be postulated for their actions, including gene 
duplication, mutations in promoter or RNA binding sites, or 
conformational changes in mRNA which, in turn, could affect its 
processing or translation. All of these would be expected to act in a 
cis manner. 
Induction and repression genes 
These genes control the synthesis of a structural gene in response to 
an effector such as a hormone or metabolite. 
Receptor protein genes 
Strictly speaking, these are structural genes, but as their presence 
or absence can affect the concentration of an intracellular protein 
they can be classed as regulatory genes. 
2.1.4. Temporal genes 
Temporal genes are loci which affect the developmental profile of 
genes during differentiation. Mutation in these genes alters the 
developmental profile. In addition to genes which are translated and 
transcribed, there are also genes whose primary transcripts are 
functional in their own right. These include ribosomal RNA genes and 
transfer RNA genes. Other small RNA particles are also transcribed 
which are normally found in a complex with protein (snRPs), and may 
have a regulatory role. 
2.2 Gene complexes (Paigen, 1979) 
Genetic and molecular evidence has led to the proposal that structural 
genes are situated in a complex of DNA sequences which contain a great 
deal of regulatory information in the form of untranscribed regulatory 
elements and genes. A complex can be described as a haplotype which 
describes the alleles of the structural gene and regulatory genes in 
the gene complex. One gene complex which has been described in detail 
is that of f3-glucuronidase. The structural gene, Gus-s defines the 
location of the (Gus] complex and has been mapped to the distal end 
of the chromosome 5 (Paigen and Noell, 1961; Sidman and Green, 1965), 
and several alleles have been described. Linked to Gus-s there are 
several regulatory genes: Gus-r controls androgen induction and acts 
in acis manner (Swank et al., 1978), Gus-t regulates temporal 
expression of the complex although paradoxically it appears to act in 
trans (Lusis et al., 1983) as does Gus-u 
2.3 Regulatory elements 
Apart from regulatory elements which can be classed as separate genes, 
there also exist regulatory elements consisting of short concensus 
sequences mostly found 5' to the coding sequences. These have been 
found by the cloning and sequencing of 	genomic DNAs. In the genes 
24 
25 
of higher organisms, genomic sequences have proved to be much larger 
than the corresponding mRNA. The primary transcript, as transcribed 
from the DNA, contains a vast number of sequences which are removed 
during the processing of the transcript. These sequences interrupt the 
mature mRNA sequences at intervals and have been termed "intervening 
sequences" or "introns" (Jeffreys and Flavell, 1977; Tilghman et al., 
1978). The mRNA sequences are termed "exons". The introns contain 
consensus sequences for their splicing out and may also contain other 
regulatory elements (Breathnach et al., 1978). 
The sizes of the largest transcripts observed for several genes, 
e.g. P-globin (Tilghman et al., 1978) and ovalburnin (Roop et al., 
1978) are consistent with transcription initiating at the 5' end of 
the first exon and terminating at the 3' end of the last exon. 
2.3.1. The Cap Site 
Initiation occurs at the nucleotide corresponding to the first capped 
nucleotide of the mature mRNA (Waslyk et al., 1980; Luse and Roedor, 
1980). No precursor molecules with 5' termini extending upstream from 
the cap site have been discovered (Weaver and Weissman, 1979). 
2.3.2. The Goldberg-Hogness box 
The Goldberg-Hogness box or TATA box is found about 30 base pairs (bp) 
upstream from the transcription initation site in the majority of 
genes transcribed by RNA polymerase II (Goldberg, 1979). Changes to, 
or deletions of, the TATA box in vitro greatly reduce, or prevent, 
the initiation of transcription (Zaruki-Schultz et al., 1982;) 
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- 	- 	 .. In vivo the site of initiation, rather than the 
efficiency of initiation, appears to be affected (Benoist and Chambon, 
1981). 
2.3.3. The CCAAT Box 
The consensus sequence CCAAT occurs at -70 to -80 bp from the cap site 
in the majority of eukaryotic genes (Efstratiadis et al., 1980; 
Benoist et al., 1980), although its precise function is not clear. 
2.3.4. Enchancer Elements 
Enhancers often occur typically 100-300 base pairs upstream. These are 
distinguished by their ability to activate transcription independently 
to their orientation and precise positioning in relation to the 
transcriptional unit. 
2.3.5. Polyadenylation sites 
Polyadenylation sites appear downstream from the AUG codon and are at, 
or close to, the transcription termination site (Roop et al., 1980; 
Tsai et al., 1980). The site is adenine rich and usually of the form 
AATAAA (Proudfoot and Brownlee, 1976; Hagenbuchteet_al., 1980). Read-
through polyadenylation sites can occur and in some cases provide a 
means of genetic control, as in the production of the secreted and 
membrane bound forms of 1gM (Early et al., 1980). 
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2.3.6. Hormone induction sites 
Upstream 5' sequences have been identified in several systems 
regulated by hormones, and consensus sequences for both oestrogen and 
progesterone have been deduced. The simplest model of steroid 
regulation assumes the formation of a hormone-receptor complex, and it 
is assumed that these consensus sequences will be hormone binding 
sites. 
A sequence 500 bp 5' to the human growth hormone gene enables 
induction by glucocorticoid hormones (Robins et al., 1982). 
Similarly a region 250-300 bp upstream from the cap sites of 
progesterone-regulated chick oviduct proteins is essential for 
progesterone binding (Mulvihille et al., 1982), and the consensus 
sequence 5'ATCATTTCTGTTGTA3' has been derived. In Xenopus, 
vitellogenirt genes, (which are oestrogen induced), when compared with 
the chicken gene have revealed a pallindromic sequence 5 'GGTCANNNTGACC-3' 
which is present in 1-3 copies in front of each gene (Walker et al., 
1983). The same sequence is also present in the chicken apo-VLDL II 
gene. The Xenopus sequence can be made to function in human cells 
(Klein-Hitpa et al., 1986), indicating conservation of these 
control elements. 
2.3.7. Tissue Specific Regulatory Elements 
Tissue specific 5' regulatory elements have been isolated, for example 
for insulin (human and rat), and chymotrypsin (rat), by linking putative 
control elements to the 'reporter' gene chloramphenicol acetyl 
transferase (CAT). The position of the element which gave the 
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specificity, varied from -168 - -258 for human insulin, -247 - -302 for 
rat insulin, and -192 - -274 for rat chymotrypsin. This position was 
found to roughly correspond to a DNase I hypersensitive region. It is 
possible that the element is involved in the process of generating an 
open chromatin structure. Sequences similar to viral enhancer 
sequences were also found, but were not involved in tissue specificity. 
It has been proposed that a trans-acting positive regulatory factor, 
(the differentiator), interacts with the 5' control element, leading to 
selective expression in the differentiated cell (Walker et al., 1983). 
2.3.8. Intron/Exon splice sites 
Introns are transcribed as part of the primary transcript and are then 
cleaved out by a process known as RNA splicing. There are three 
classes of spl'Lcing for mRNA, tRNA and rRNA. mRNA splice sites always 
have the consensus sequence 
A 	A 	 G 
5' AGGT AGT------(P ) 6xCAGG 3' 
C 	G intron Y 	T 
(Breathnach and Chambon, 1981; Sharp, 1981). 
Unlike mRNA's, tRNA precursors have no consensus sequences for 
their splice sites, thus leading to the conclusion that the main 
determinant for splicing lies within the conformation of the precursor 
tRNA itself (Colby et al., 1981; 	 - 	 Peebles 
et al., 1983). 
In Tetrahymena rRNA the intron plays an active part in its own 
excision and appears to be an auto-catalytic activity (Kruger et 
a].., 1982; zaug et al., 1983). Mitochondrial RNA and other rRNAs 
are also believed to excise introns similarly (Cech, 1983). 
2.3.9. Other regulatory elements 
Two other control regions have been identified which are a guanosine 
rich segment between bases -47 - -61, and a cytosine rich region 
between bases -80 - -105. Mutations in either region vastly reduce 
efficiency of transcription (McKnight and Kingsbury, 1982). 
2.4 Trans-.acting regulators 
As well as being controlled by linked regulatory genes and sequences, 
as described in the previous section, gene expression is also 
controlled by trans-acting regulatory genes and trans-acting 
modifiers. Such regulators would include hormones binding to 
regulatory sites (Section 2.4.7), metabolites acting as an 
inducer/repressor at regulatory binding sites or the gene products of 
trans-acting regulatory genes. Such regulation is required as a 
response to a physiological need, such as would be found in response 
to hormones, or to initiate tissue specific expression by regulation 
with tissue specific metabolites. Enzymes under co-ordinate control, 
whose structural genes are not closely linked, must be co-ordinately 
expressed by the use of trans-acting factors. Several such distal 
regulatory loci have been described, the majority of which appear to 
be connected with temporal or developmental transcription. These 
include genes which affect the expression of -glucuronidase (Lusis 
and Paigen, 1975)13 -galactosidase (Berger et al., 1979) and the 
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Rif/raf system which comprises two unlinked regulatory genes 
controlling the levels of a-fetoprotein (Belayew and Tilghman, 1982; 
Pachnis et al., 1984). The Rif/raf system also appears to be an 
example of regulatory loci co-ordinately controlling several genes, as 
screening for mRNAs with the same developmental profile as a-feto-protein 
produced another gene product which was also under control of Rif 
and raf. The protein has not been identified and has been called H19 
(Pachnis et al., 1984). 
Several trans-acting regulators for the tissue specific 
expression of genes have been proposed. Transgenic mice have been 
produced with a stably integrated DNA sequence consisting of the 
type 1 collagen upstream sequences (-2000 - +54) linked to 
chioramphenicol acetyl transferase (CAT) (Khillan et al., 1986). 
Expression of CAT followed the tissue distribution patterns ofa 2 (1) 
collagen, concluding that the a 2 (1) collagen sequences present in the 
recombinant plasmid contained sufficient information to ensure tissue 
specific activity. Presumably this was mediated by a tissue specific 
diffusible trans-acting regulatory factor interacting with the a 2 (1) 
collagen sequences. 
Trans-acting regulatory factors have also been proposed for the 
control of insulin expression (Nir et al., 1986; Walker et al., 
1983). Using recombinant plasmids containing upstream insulin DNA 
sequences, intracellular competition experiments indicated the action 
of a negative trans-active factor in non-insulin expressing cells, which 
is over-ridden in insulin producing cells by a positive trans-acting 
factor(s). These factors appear to act by interacting with the 
upstream DNA sequences (2.3.7). 
Similarly the selective expression of rat pancreatic genes during 
embryonic development (Han et al., 1986) appears to be controlled by 
multiple regulatory molecules to achieve co-ordinated expression. 
Recombinant DNA technology should reveal eventually the molecular 
basis for these interactions. 
2.5 The differential expression of multiple mRNAs from single genes 
Increasing numbers of genes have been discovered which are capable of 
producing multiple mRNAs from a single structural gene. These mRNAs 
may differ only in the untranslated regions or may involve differences 
in the translated region and thus produce different proteins. The mode 
of regulation for such genes appears to fall into three classes. 
The first type of regulation is that seen amongst immunoglobulin 
genes to provide the vast array of immunoglobulins required for the 
immune response. This mechanism requires the re-arrangement of DNA and 
the association of genetic sequences previously far apart (Tonegawa, 
1983). 
The other two mechanisms do not require DNA re-arrangement, but 
instead produce several mRNAs from a single contiguous genomic DNA 
sequence by differential transcription and/or splicing. 
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The first method allows the production of several different 
primary transcripts, the second method produces one primary transcript 
which is differentially spliced. 
The production of several primary transcripts has been observed 
for several genes. Mousea'-antylase (Schibler et al., 1983) and 
Drosophila alcohol dehydrogenase (Benyajati et al., 1983) appear to 
control levels of the protein by the differential choice of promoters. 
The different 5' non-translated sequences thus produced affect the 
rate of translation of the final protein. 
For Drosophila myosin light chains 1 and 3, and rat amylase A and B 
(Robert et al., 1984; Tsutsuini et al., 1984; Numazaki et al., 
1984) different primary transcripts appear to involve conformational 
differences which, in turn, affect the splicing pattern. 
The final mechanism for the production of multiple mRNAs is the 
alternative stage or tissue specific splicing of a single primary 
transcript, a common viral mechanism for maximising the potential of 
a limited genome (Ziff, 1980). In cellular genes this has been 
observed for rat 11-fibrinogen (Crabtree and Kant, 1982), Drosophila 
myosin heavy chains (Rozek and Davidson, 1983),a-A-crystallin (King 
and Piatigorsky, 1983) and Troponin T (Medford et al., 1984). With 
increased molecular analysis of these and other systems, themolecular 
basis for these regulatory effects, and their interaction with trans-
acting stage and tissue specific modifiers, should be elucidated. 
Investigations to be undertaken 
As described in Chapter 1, pyruvate kinase is a useful model system 
for the study of gene expression. 
The aims of this work were to analyse biochemically and 
genetically several putative regulatory mutants of Pk-1: 
To determine by immunoprecipitation if the phenotypic 
variation was due to structural or regulatory gene mutations. 
To determine if the regulatory genes were linked to the 
structural gene. 
To determine the interactions of the regulatory mutations. 
To map Pk.-1. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Animals 
The laboratory inbred strains C57BL/6, SWR, C3H/He, DBA/2 and BALB/c 
were obtained from Bantin and Kingman, Crimston, Hull, U.K. 
The strain segregating for the Pk_3r allele (Johnson et al., 
1981) was obtained from Dr J. Peters, MRC Radiobiology Unit, Didcot. 
The Pk_3r  allele was maintained in heterozygotes as the 
homozygote is lethal. 
A strain with increased Pk-1 activity (MUN) was obtained from Dr 
W. Pretsch and Dr D. Charles, Institut ftir Genetik, 8042 Neuherberg, 
FRG (Charles & Pretsch, 1984). 
Wild mice, with low activity phenotypes, were trapped in 
Edinburgh, W(Pk_lb/Pk_lI)  and PKD; and Leicester; PKL. These 
were maintained as true breeding stocks for the altered phenotype at 
the Institute of Animal Physiology and Genetics Research (Roslin) 
(Bulfield et al., 1983). 
Six recombinant inbred strains derived from SWR and C57L (SWXLs) 
and progenitor animals were obtained from Dr B. Taylor, Jackson 




Livers, shipped in dry ice, from 12 recombinant inbred strains derived 
from C57BL/6J and C3H/J, and livers from the progenitor animals were 
supplied by Dr B. Taylor, Jackson Laboratory, Bar Harbor, Maine, 
U.S.A. 
3.1.3 Chemicals 
All chemicals, except where otherwise stated, were obtained from the 
Sigma Chemical Company and radiochemicals were obtained from Amersham 
International. 
3.1.4 LKB Interface 
An interface with software was designed and built by J. Parker, 
Lecturer, Faculty of Electronic Engineering, West Glamorgan Institute 
of Higher Education, Mount Pleasant, Swansea SAl 6EP, to interface an 
LKB Kinetic Analyser with a Commodore 64 home computer. The LKB 
reaction rate analyser 8600 was factory set at 30 0C and allows 
optical density to be read continuously in a reaction after the 
injection of one or two substrates. Injection of substrate and the 
length of time of measuring optical density are automatic. 
3.2 Methods 
3.2.1 Protein Estimation 
The Bradford method (Bradford, 1976) was chosen as a quick and 
reproducible assay over the range of protein concentrations used. The 
BioRad ready prepared dye concentrate was diluted with water and 
filtered before use and colour development was measured at 595nm. 
Protein concentration was measured by calibration with Bovine Serum 
Albumin. 
3.2.2 Tissue Preparation 
When blood was not required, the animals were killed by cervical 
dislocation and the appropriate tissues excised and kept on ice until 
used. If the tissues were not to be used immediately they were stored 
at -80 0C. Pyruvate kinase has been shown to be stable for at least 
6 months in tissues kept at this temperature. 
The tissues were rinsed in ice cold phosphate buffer (pH 7.4, 
50mM) and weighed. Samples were homogenised using a Tri-R homogenizer 
(5 passes) in 10 x v/w of phosphate buffer. The homogenate was 
centrifuged at 20,000g for 10 mins at 4°c, the supernatant was 
removed and stored at -80 °C if not used immediately. 
When blood was required, the animals were first anaesthetized with 
ether. Anaesthesia was maintained by placing a small container 
containing cotton wool soaked in ether over the animal's head. The 
thoracic cavity was revealed and a small incision made into the heart 
and blood was collected from the thoracic cavity using a pastette 
which had previously been rinsed with heparin (5000iu ml- 1 H20). 
Blood samples were lysed using 9:1 vol:vol Triton X100 (0.1% in 
phosphate buffer, pH 7.4, 50mM). 
3.2.3 Pyruvate Kinase Assay (Bulfield and Moore, 1974) 
Pyruvate kinase (EC 2.7.1.40) (PK) was assayed by following the 
(1.1 
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decrease in concentration of NADH which occurs when pyruvate kinase is 
linked to lactic dehydrogenase (LDH). 
+2 
K , Mg 




ADP 	 ATP nADHN 
The concentration of NADH was measured by following the decrease in 
absorbance at 340nin. 
The following reaction mixture was prepared daily in phosphate 
buffer (pH 7.4, final concentration 25mM). 
Final Concentration 
KCl 	 37.0mM ) prepared in H 20. Stored 
MgC12 	 5.0mM ) at room temperature. 
ATP 	 26.0mM ) prepared in phosphate buffer 
FDP 	 1.1mM ) 	(pH 7.4, 50mM). Stored at -20 °C 
NADH 	 0.15mM 	prepared in phosphate buffer daily 
LDH 	 320iu ml- 1 prepared in phosphate buffer, 
stored at +40C. 
Twenty ul of enzyme were added to 900u1 of reaction mixture; the 
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reaction was initiated by the addition of lOOul PEP 6.6mM in phosphate 
buffer (pH 7.4, 50mM). Optical density change over 1 minute was 
measured using an LKB kinetic analyser interfaced to a Commodore 64 
computer. 
3.2.4 Preparation of agarose isoelectric-focusing gels 
The following reaction mixture was prepared and poured into a prepared 
mould at 37 °C. 
Agarose (IEF grade) 	0.3gm 
Sorbitol (Fisons) 	3.6gm 
Distilled water 	27.Oml 
Ampholine pH 3-6 	0.46ml 
Ampholine pH 5-8 	0.46m1 
Gels were cast on gel bond for ease of handling and left for 30mins at 
37°C, followed by 1 hour at 4°C. 
3.2.5 Isoelectric-focusing (IEF) 
The prepared gels were run using the LKB multiphor system. The 
following initial conditions were used. 
Max Volts 	 1000V 
Max Amps 	 20mAmps 
Initial Watts 	 7.5 watts 
Gels were run for 1.5 hours. Samples were applied using small squares 
of filter paper halfway between the cathode and the centre of the gel. 
The filter papers were removed after 15 mins. On completion of 
focusing (ainpage less than 2.OmAmps) the gels were stained using an 
agar overlay. 
3.2.6 Pyruvate Kinase Stain 
A 2% solution of agar in phosphate buffer (pH 7.4, 50mM) was prepared 
by boiling. On cooling to 60°C an equal volume of the following 
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LDH 600 iu ml- 1 
in phosphate 
buffer, pH 7.4, 
50mM 
The agar mixture was poured over the gel and left to incubate for 15 
mins. The gels were visualised under UV light and photographed. 
3.2.7 Purification of the antisera (Goding, 1978; Tanaka personal 
communication) 
Solutions: 	(1) Phosphate buffered saline (PBS) 
phosphate buffer pH 7.4, 50mM + NaCl 0.15M 
Acetic acid 
Acetic acid 10.1mM + NaCl 0.15M 
Tris buffer 
Tris-HC1 buffer pH 9.0, 0.1M 
Rat crude antisera to PK-L and PK-M, as a lyophilised powder, was 
the gift of Professor T. Tanaka, University of Osaka, Japan. It was 
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reconstituted to its original concentration (30mg ml- 
1 
 in phosphate 
buffered saline (PBS) and dialysed overnight against 5 litres of PBS 
at 4°C. 
One ml of antiserum was applied to an affinity column consisting 
of 3m]. protein A sepharose equilibriated at room temperature with 
PBS. The column was eluted with PBS until the optical density of the 
eluate was less than 0.1 OD units at 280nm. Acetic acid was applied to 
the column and imi fractions collected into 0.15m1 ¶rris buffer to 
neutralise the pH. Fractions with the greatest optical density at 
280nm were pooled and dialysed overnight against 5 litres PBS at 
0 
4 C. A typical elution profile is shown in Figure 3.1. 
The antiserum was standardised using enzyme extracted from C57BL/6 
livers. 
3.2.8 Immunoprecipitation of pyruvate kinase (Noguchi et al., 1982) 
Tissue supernatant was diluted appropriately with phosphate buffer (pH 
7.4, 50mM) to give an OD change of 0.2 units min- 
1. 
 This value was 
chosen after calibration to optimise enzyme activity for the assay. 
Increasing volumes of enzyme were added to a fixed volume of the 
appropriate antiserum, suitably diluted. Each tube was made up to a 
constant volume with phosphate buffer (pH 7.4, 50mM). When liver PK was 
being analysed, an excess volume of anti PK-M antiserum was added as 
20% of liver PK activity is due to PK-M 2 . The tubes were incubated at 
room temperature for 15 mins after which 5u1 Protein A (0.2gm rnl1) 
Elution with PBS 
II 
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A typical elution profile for the purification of rat PK-M and 
rat PK-L antisera using a protein A Sepharose affinity column. 
( 
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was added. The tubes were incubated for a further 15 mins at room 
temperature and then centrifuged at 4000g for 15 mins at 4 °C. 
Residual PlC activity was measured on the supernatant. It was found 
that with the exception of blood, zero residual activity could not be 
achieved. This was shown to be an endogenous background reaction which 
occurred without the addition of PEP. Attempts to remove this 
background activity by dialysis, gel filtration or ultra 
centrifugation of the supernatant were unsuccessful. As this reaction 
appeared to be variable, correlating to a certain degree with the 
batch of LDH being used, it was always measured and substracted from 
the experimental readings. 
The protocol for the irnmunoprecipitation is given below: 
Enzyme ul 0 10 20 30 40 50 
Anti PK-L/50 or Anti M/50 	ul 10 10 10 10 10 10 
Anti PK-M/4 (Liver only) 	ul 10 10 10 10 10 10 
Buffer ul 80 70 60 50 40 30 
Protein A ul 5 5 5 5 5 5 
Total volume 95u1 (105u1 Liver) 
The results were analysed as in the following examples. The activity 
profiles of 3 mice differing phenotypically in enzyme activity are 
shown in Figure 3.2 without added antiserum. If the variation in 
activity was due to differences in enzyme structure and not the number 
of enzyme molecules, the results found on adding a fixed level of 
antibody would be as shown in Figure 3.3. All three animals would have 
an intercept shifted by the same amount, slope being unaffected. On 
the other hand, if the animal with the highest PlC activity had an 
Measured 
activity 
Increasing volume of enzyme in assay 
FIGURE 3.2 
The activity profile of mice with three activity phenotypes on 
increasing the volume of enzyme in the assay. 
A - High activity phenotype 
B --- Normal activity phenotype 
C ... Low activity phenotype 
Measured 
activity 
Increasing volume of enzyme in assay 
FIGURE 3.3. 
The activity profile expected 
the PK enzyme on the addition of 
A - High activity - Increased 
B --- Normal activity 
C ... Low activity - Decreased V 
from structural differences 




increased number of enzyme molecules and the animal with the lowest 
activity a decreased number of enzyme molecules, the results would be 
as in Figure 3.4. The animal with the highest number of enzyme 
molecules u1 1 will bind all the antibody added using a smaller 
volume of enzyme than the animal with the lowest number of enzyme 
molecules ul ' . Once all the antibody is bound, residual PK activity 
can be measured. The intercept is the volume of enzyme required to 
bind all the antibody in the fixed amount added. 
Thus intercept is inversely proportional to the number of 
molecules. Again slope is not affected. The slopes in all cases are 
directly proportional to the measurable activity. This method produces 
straight lines with slopes and intercepts determined by regression 
analysis, thus allowing the results to be analysed statistically. 
3.2.9 Nephrectoifly 
As the stock containing the Pk3 ' allele was maintained as the 
heterozygote, heterozygous offspring, to be used for further breeding, 
were identified by the removal and assaying for PK activity of a 
kidney. 
Mice were anaesthetised by the injection of 2nil Sagital (10% in 
0.15M NaCl) intraperitoneally. A small incision was made into the side 
of the mouse just below the rib cage and the kidney gently lifted out 
of the body. The kidney was removed and the wound cauterised at the 
same time by using a red hot scalpel blade. The incision was clipped 




Increasing volume of enzyme in assay 
T'T ('T1t I I. 
The activity profile expected from enzyme number differences 
in the PK enzyme on the addition of a fixed amount of anti- 
body. 
A - High activity - increased enzyme number 
B --- Normal activity 




Determination of pyruvate kinase concentration in kidneys of 
animals with the mutation 	at the pj 	locus 
4.1 Introduction 
During screening of pyruvate kinase activity in the kidneys of several 
hundred female C57BL/6J mice, one variant was found with half the 
normal activity (Johnson et al., 1981). The animal transmitted the 
trait and a single gene responsible for the activity was identified 
and mapped to Chromosome 9 by its linkage to Mod-1 and d. A 
spontaneous mutation is believed to be responsible for this mutation 
(Johnson et al., 1981), and was called Pk-3
r 
. 
This allele, in conjunction with an electrophoretic allele of Pk-3 
(Pk_3b) (Peters et al., 1981), was used to show that both were 
allelic forms of Pk-3, and that heart (PK-M 1 ) and kidney (PK-M2 ) are 
determined by the same structural gene (Peters & Andrews, 1984). The 
Pk-3 
r 
 heterozygotes have 50% of the PK activity of Pk3 a 
animals in both kidney (PK-M 2 ) and muscle (PK-M 1 ) (Table 4.1). 
Table 4.1 The pyruvate kinase activity of C57BL/6 and Pk_3r 
heterozygotes 
Specific Activity m Units mg- 1 + S.E. 
KIDNEY (PK-M2 ) 	MUSCLE (PK-M 1 ) 
Pk_3 a/Pk_3a (C57BL) 	48 + 3.6 
	
985 + 31.0 
Pk_3a/Pk_31 	 25.6 	2.9 
	
513 	27.4 




a animals were analysed. 
The 	allele was maintained by crossing heterozygous 
males to normal females. Of f spring were then tested for the Pk_3r 
allele by the removal and assaying of a kidney. Heterozygotes were 
used for further matings. 
In order to determine if the decreased activity was due to a 
reduction in the number of enzyme molecules or to a decrease in 
V, the enzyme concentration in normal and heterozygous animals 
was determined by immunoprecipitation with rat PK-M antiserum, a gift 
from Professor T. Tanaka, University Medical School, Osaka, Japan. 
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4.2 Results 
Ixnmunoprecipitation was carried out as described in section 3.2.8. The 
intercept for the heterozygotes (Pk_3r,Pk_3a)  is approximately 
twice that of the homozygote (Pk_3a) (Fig. 4.1, Table 4.2). As 
the interecept is inversely proportional to the number of enzyme 
molecules present, this increase reflects a decrease in the number of 
enzyme molecules by approximately 50%. The resulting decrease in 
measurable enzyme activity is reflected in the 2 fold decrease in the 
slope of the graph for the heterozygotes. These results are summarised 
in Table 4.3. 
4.3 Discussion 
The results indicate that the heterozygotes have approximately 45% of 
the number of enzyme molecules as the progenitor mice (Tables 4.2 and 
4.3). 
If this is considered with the fact that the homozygous mutant is 
lethal it is probable that the mutant gene is either inactive or 
active only at a very low level; there are several possibilities 
which could account for this data. 
The gene is defective in such a way that transcription does 
not occur, or occurs only at a very low level. 
A mutant RNA message is produced which either cannot be 
processed or cannot be translated. 








10 	20 	30 40 	50 	60 
p1 Enzyme in a total volume of 95 p1 
FIGURE 4.1. 
An analysis of the Pk_3r  mutation using immunoprecipitation with a fixed amount 
of anti PK-M antiserum. 
Table 4.2 A comparison of the slopes and intercepts after 
immunoprecipitation Of C57BL/6 and heterozygotes in 
the kidney 
( Pk_3a,Pk_3a) 	 (Pk_3a,Pk_3I) 
Slope 
	
2.41 + 0.01 
	
1.1 • 0.02 
Intercept 
	
1.2 + 0.17 
	
2.74+ 0.2 
Number of Animals 	 4 
	
4 
Table 4.3 The relationships between the slopes and intercepts of 
C57BL/6 and heterozygotes 
B6/heterozygote ratio 
Ratio slopes 	 1.1/2.4 = 45.5% 
Inverse ratio-intercepts 	1.2/2.75 = 44.4% 
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Samples of the mutant mice have been sent to Professor T. Tanaka, 
University Medical School, Osaka, Japan who has done further molecular 
studies on these mice. The results show that both normal and 
heterozygous animals have similar-levels of heterogeneous nuclear RNA 
(HnRNA) (Table 4.4), although the heterozygote level is in fact higher 
than the homozygote. 
This might suggest that heterozygouse animals have increased 
levels of transcription to compensate for the decrease in the amount 
of mature RNA found at a later stage in processing. In fact a decrease 
in the level of mature mRNA is shown by the dot blot results (Table 
4.4). The mutation does not therefore appear to be a transcriptional 
mutation, but a mutation in the processing mechanism which produces 
the mature mRNA from the primary transcript. Such a mutation may 
affect either the conformation of the primary transcript-producing 
molecules which do not have the correct conformation for efficient 
action of processing enzymes, or the splice sites may be altered again 
allowing inefficient action of the processing enzymes. 
A further possibility which cannot be ruled out is rapid 
degradation of the mutant RNA so that translation cannot occur. 
To conclude, the Pk_3r  mutant affects enzyme concentration. 
The level of enzyme loss indicates that very little or no protein is 
produced by transcripts from Pk_3r.  Molecular analysis indicates 
that the effect is post-transcriptional. Molecular analysis of this 
mutant is at present being completed by Professor T. Tanaka (Osaka). 
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TABLE 4.4 The Pyruvate Kinase Activity of M type and the Amount 
of mRNA Measured by Dot Blot and Northern Blot 




(U/mg at 30 C) 
mRNA (dot) 
mRNA (Northern) 
Large (4.4 - 4.6kb) 
Small (2.6kb) 
Kidney 
Ni N2 Ml M2 
8.19 8.60 4.98 4.70 
8.55 6.45 2.30 3.95 
2.34 2.12 2.70 3.38 
14.80 9.75 5.88 5.70 
mRNA (dot) 	 2.50 1.90 10.20(?) 	0.90 
mRNA (Northern) 
Large (4.4 - 4.6kb) 2.79 4.28 
Small (2.6kb) 1.73 0.99 
Liver 
mRNA (L-type, dot) 	4.30 4.50 3.90 	4.40 
N = normal animal (Pk_3a,Pk_3 a) 
M = heterozygote (Pk_3r/Pk_3a) 
Unit in hybridisation experiments is integrated unit of 
reading values by densitometer. 
CHAPTER 5 
Activity phenotypes of pyruvate kinase; immunological 
characterisation 
5.1 Introduction 
In order to analyse the genetic regulation of gene expression, it is 
necessary to have a variety of regulatory gene mutations to allow the 
different elements of the regulatory system to be separated and 
analysed. As there is limited genotypic variation between the common 
strains of inbred mice, it is difficult to find activity differences 
large enough to be genetically analysed. This can be overcome by 
screening populations of wild mice (Bulfield et al., 1983). A survey 
of laboratory and wild mice (Moore and Bulfield, 1981) resulted in the 
detection of erythrocyte pyruvate kinase activity variants. The wild 
mice were established as true breeding strains for decreased PlC 
activity. The activities of these phenotypes are given as a percentage 
of C57BL/6 activities in Table 5.1 aand as specific activities in 
Table 5.2. Two of these phenotypes, W(Pk_lb/Pk.lb)  and SWR, 
have been previously partially analysed (Moore, 1981). Liver and RBC 
PlC in mice with the w phenotype, was heat labile, on the other hand 
liver PK from animals of the inbred strain SWR did not differ in heat 
stability or any other aspects 	structure such as kinetic or 
electrophoretic mobility, but did however have a tissue specific 
decrease in liver PlC activity. Genetic analysis of the W phenotype 
indicated a single gene difference. The segregation analysis of SWR, 
though not as clear, also indicated a possible single gene difference. 
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TABLE 5. 1. Pyruvate Kinase Activities of a Series of Phenotypic 
Variants expressed as a Percentage of C57BL/6 Activity. 
Phenotype Activity Source 
(Percentage C57BL/6) 
Liver Blood 
C57BL/6 100 100 Laboratory inbred 
W 25 41 Wild (Leicester) 
PKD 35 70 Wild (Edinburgh) 
PKL 43 65 Wild (Leicester) 
C3H/He 50 100 Laboratory inbred 
MUN 115 220 ENU Mutation 
of C3H/J 
SWR 40 100 Laboratory inbred 
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TABLE 5.2. Specific Activity of Pyruvate Kinase in the Blood and 
























(MUNXSWR) F 1 
(Mu1xw) F 1 




7.58 + 0.17 
8.57 + 0.33 
7.52 + 0.20 
7.40 + 0.27 
16.90 + 0.32 
3.13 .!: 0.33 
5.60 ± 0.28 
5.76 + 0.25 
11.70 + 0.27 
15.30 + 1.04 
9.49 1- 0.17 
7.20 0.35 
LIVER 
n Specific Activity 
+ S.E. 
28 82.0 + 2.80 
14 35.3 + 1.45 
19 42.8 + 2.40 
2 56.5 + 2.50 
22 101.0 + 4.40 
11 17.8 + 1.08 
8 36.6 + 3.22 
10 26.5 + 1.95 
10 83.7 + 4.70 
10 97.4 + 4.60 
10 57.9 + 2.00 
20 68.5 + 3.50 
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Two other activity variants, PKD and PKL, also appeared to be 
structurally equivalent to C57BL on the basis of heat stability, 
kinetic and electrophoretic data (Moore; 1981). Both these strains were 
regarded as possible regulatory mutations. 
A second tissue specific PK activity variant was found in the 
inbred strain C3H/He (Table 5.1). No previous biochemical analysis has 
been performed on this strain. A different sublirie of C3H, C3H/E1 
was used in a mutaqenesis experiment with 1-ethyl 1-nitrosourea as the 
mutagen on (101/El x C3H/El).F 1 hybrid animals. These carry the C3H/E1 
Pk-1 gene (Charles and Presch, 1984). From this experiment an 
animal with increased RBC PK activity was found (Charles & Pretsch, 
1984). This phenotype referred to as MUM was made available by Dr D. 
Charles and has been analysed biochemically and genetically and shown 
to be a single gene mutation. The enzyme shows no discernible 
structural differences from the C3H/E1enzyme (Charles & pretsch, 
1984). 
C3H and SWR phenotypes appear to be of particular interest as the 
effect is tissue specific and may shed light on the tissue specific 
expression of PK-L and PK-R in liver and blood. 
In conclusion, several mutations affecting enzyme activity are 
available. Two, C3H and SWR, show a tissue specific decrease in liver 
PK activity. MUM shows a systemic increase in activity when compared 
to C3H, whilst w(pk_lb,,pk_llD) PKD and PKL show a decrease in 
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liver and RBC PK activity. To establish if these variants are due to 
altered enzyme concentration or to an as yet undetected structural gene 
difference, the amount of enzyme present was measured by using the 
ixnmunoprecipitation technique described in section 3.2.8. 
5.2 Results and Discussion 
The results from the immunoprecipitation of liver and RBC PK show two 
of the variants to have intercepts statistically different to that of 
C57BL/6 (Figs. 5.1 & 5.2; Tables 5.3 & 5.4). These are animals of the 
phenotypes MUN and SWR. The intercept of MUN in liver and blood is 
approximately 50% that for the intercept of C57BL/6 and of its 
progenitor strain C3H. Providing there is no difference in antibody 
binding between these variants, which is likely, these results 
indicate that MUN has twice the number of enzyme molecules per ml, as 
half the amount of enzyme is required to bind the antibody in MUN as 
is required by C3H and C57BL/6. 
The increased slope of liver and RBC PK activity from animals of 
the MUN phenotype compared to those of the C3H phenotype, is a direct 
reflection of the increased measurable activity caused by the 
increased number of enzyme molecules. There is nothing to indicate a 
difference in V 
max 
 between these phenotypes. 
The second variant to have a statistically altered intercept is 
SWR; the value for the liver PK is over twice that of C57BL/6 liver 
PK, thus indicating a decrease in the number of molecules present in 
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p1 Enzyme in a total volume of 105 p1) 
Fixed volume of antiserum 
pT(rTR1 c1 
Inununoprecipitation of pyruvate kinase from the activity phenotypes 
using anti PK-L antiserum. The method was as described in Section 
3.2.8. 
The error bars represent the SE of the slope at each point as 
calculated from the linear regression of the data. 
Number of animals (n) = 10 
C3H)_ 20 
MUN) 	- 
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pt Enzyme in a total volume of 95 p1 
Fi::erl vo1uia of antiserum 
FIGURE 5.2 
Iinmunoprecipitation of pyruvate kinase from the activity phenotypes 
using anti PK-L antiserum. The method was as described in Section 
3.2.8. 
The error bars represent the SE of the slope at each point as 
calculated from the linear regression of the data. 




each assay was in triplicate 
reflected in the decreased slope (Fig. 5.1, Tables 5.3 & 5.4) of SWR. 
No difference in interecept or slope was seen with blood PK (Fig. 
5.2). As the intercepts and slopes are statistically identical in the 
blood but altered in the liver (Tables 5.3 & 5.4), a tissue specific 
alteration in the number of enzyme molecules is indicated. 
A third phenomenon of interest is the difference between C3H/He 
and C57BL/6 liver PK activity. C3H/He has a tissue specific decrease 
in measurable liver PK activity. This is reflected in the decreased 
slope of C3H/He in the liver (Fig. 5.1). However C3H/He and C57BL/6 
have a common intercept, thus indicating the presence of the same 
number of enzyme molecules. The difference in activity must therefore 
be due to a structural gene mutation affecting V max • These 
phenotypes will be discussed in further detail in the following 
chapters. 
The results for the PKD and PKL phenotypes indicate that like the 
w(Pk_lb/Pk_l) phenotype, they too are structural gene mutations. 
It had been shown previously (Moore, 1981) that these phenotypes did 
not differ from C57BL in heat stability, kinetics or electrophoretic 
mobility, although structural differences do not necessarily alter any 
of these characteristics. During the immunoprecipitation experiments 
however, it was noted that these phenotypes appeared to lose activity 
on repeated freezing and thawing. A controlled freeze/thaw experiment 
was therefore carried out (Table 5.5). 
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TABLE 5.3. Slopes and Intercepts for PK Activity Variants in Blood 
and Liver (+ S.E.). 
Phenotype 	 LIVER 	 BLOOD 
Interc- Slope Intercep Slope 
C57BL/6 1.35 + 0.13 19.8 + 0.9 1.85 + 0.1 20.1 ± 1.3 
W(Pk_lb) 1.01 + 	0.11 6.6 + 	1.15 1.72 + 0.15 8.6 + 0.75 
PKD 1.19 + 0.08 8.9 + 0.25 1.95 + 0.23 9.3 + 0.9 
PKL 1.08 + 0.15 10.1 + 	1.0 1.82 + 0.09 7.5 + 0.55 
SWR 2.53 + 0.05 6.7 + 0.1 1.76 + 0.08 18.9 ± 0.5 
C3H/He 1.07 + 0.17 8.37 + 0.8 2.1 + 0.15 17.4 + 1.8 
MUN 0.51 + 0.07 22.1 + 0.8 0.85 + 0.05 38.5 1- 2.1 
TABLE 5.4. The relationship between slopes and the inverse 
relationship of intercepts to those of C57BL/6 
expressed as a percentage. 
Phenotype LIVER BLOOD 
Percentage Percentage Percentage Percentage 
Slope Intercept Slope Intercept 
w(pk_lb) 33 133 43 107.5 
PKD 44.5 111 46.5 94.8 
PKL 50.1 125 37.5 111.2 
SWR 33.5 53.3 94.5 105.1 
C3H/He 42 125.1 85.2 88.9 
MUN 110.5 264 192 217.6 
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TABLE 5.5. Residual Activity of Pyruvate Kinase after Freezing and 
Thawing a 10% Liver Homogenate Five Times 
Phenotype 	 n 	Percentag Residual Activity 
m Units mg wet weight liver 
C57BL/6 4 84 
MUN 4 82 
PKD 4 39 
PKL 4 58 
w(Pk_lb)  4 44 
C3H/He 4 37 
BALB/c 4 55 
Mus spretus (MS) 4 75 
Note: Activity was measured in m Units mg- 1 wet weight. 
58 
It can be seen that PKD and pxr, both lose activity on repeated 
freezing and thawing, presumably due to an alteration in enzyme 
structure caused by a structural mutation. The results of the 
immunoprecipitation experiments allow the activity variants to be 
classified (Table 5.6). 
It must however, be noted that the decreases observed in PK 
activity are not equal (with respect to C57BL/6 levels) in liver and 
blood. The liver decrease is higher in all three cases which show a 
systemic decrease. If the activities are expressed as a percentage of 
C3H/He however (Table 5.6a), this difference is reduced. 
The conclusion which can be drawn from this is that the C3H/He 
structural gene is nearer to the wild type (as represented by W, PKD 
and PKL) whilst C57BL/6 and SWR carry a mutation in the exclusive 
liver exon. 
However, as C57BL/6 and W have already been referred to in the 
literature as Pk_la  and  Pk_lb  respectively, C57BL/6 will be 
continued to be referred to as the standard phenotype. It must be 
noted that the difference between Pk_la  and Pk_lb , pklC and 
Pk_ld may involve two mutations. One in the exon, which is 
exclusively expressed in the liver and one which results in a systemic 
decrease in V max 
The SWR phenotype is caused by a tissue specific mutation 
affecting enzyme concentration; the MUN phenotype by systemic 
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TABLE 56. Summary and Classification of the Pyruvate Kinase 
Activity Variants. 
RELATIVE PK ACTIVITY 
PUTATIVE 
PHENOTYPE LIVER RBC MUTATION 
C57BL/6 100 100 Standard strain 
W/PKL/PKD 25-45 40-70 Pk-1 : Structural gene 
C3H 50 100 Tissue specific: Structural 
gene 
SWR 40 100 Tissue specific: regulatory 
gene 
C3H 100 100 
MTJN 230 220 Systemic regulatory gene 
Table 5.6a Activity variants of pyruvate kinase (Pk-1) expressed 
as a percentage of the level in C3H/He 
Phenotype 	 Activity 
(Percentage C3H/He) 
Liver 	Blood 
C57BL/6 200 100 
W 50 41 
PKD 70 70 
PKL 86 65 
C3H/He 100 100 
MUN 230 220 
SWR 80 100 
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mutation affecting enzyme concentration; The C3H phenotype by a 
tissue specific structural gene mutation and W(Pk_lb/Pk_lb), 
PKD and PKL phenotypes by a systemic structural mutation. These 
alleles have been named; PKD ( Pk_lc,Pk_lc), pyj (Pk._ld/Pk_ld), with Pk-1 5 
being reserved for the electrophoretic variant discovered by F. 
Bonhomme (unpublished data). 
A second series of immunoprecipitation experiments were carried out 
in parallel to the ones described above. In these experiments with 
liver enzyme, excess anti PK-L antiserum was added and no anti PK-M 
antiserum. Thus the residual activity measured is that of the PK-M 2 
present in liver at approximately 10-20% (Tables 5.7 & 5.8). The 
majority of the variants appear to have a lower level of PK-M2 than 
C57BL/6, with the possible exception of SWR, and it is possible to 
classify the variants into two groups based on high or low activity of 
PK-M2 ; this variation has not however been studied further. 
These results show that the alterations in liver PK activity are 
primarily due to changes in the activity of PK-L (expressed by the 
Pk-1 locus) and not to changes in PK-M 2 (expressed by the Pk-3 locus). 
Of the phenotypes analysed and discussed in this chapter, two are 
of particular interest in the further study of tissue specific 
regulation, these are the SWR phenotype and the MUN phenotype. 
The SWR phenotype shows a tissue specific decrease in the level of 
enzyme in the liver which may be due to a mutational change at a 
TABLE 5.7. Residual Activity in Liver after the addition of 
Excess Anti PK-L antiserum. This is equivalent to 
the PK-M2 activity. 
Phenotype 	 Specific Activity mU mg - 
wet weight liver 
C57BL/6 	 9.43 
SWR 	 6.60 
DBA 	 5.47 
C3H 	 6.04 
W 	 3.77 
PKD 	 5.66 
PKL 	 4.53 
MUN 	 4.34 
62 
TABLE 5.8. The Level of PK-M 2 activity in liver 
expressed as a percentage of the level 
in C57BL/6 
Phenotype 	 Percentage C57BL/6 PK-M2 
C57BL/6 	 100% 
SWR 	 70% 
DBA 	 58% 
C3H 	 64% 
w 	 40% 
PKD 	 60% 
PKL 	 48% 
MtJN 	 46% 
Mus spretus (MS) 	 48% 
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regulatory gene controlling the differential expression of PK-R and 
PK-L. These possibilities will be analysed more fully in the next 
chapter (Chapter 6). 
The MUN phenotype is interesting for two reasons. It has a 
systemic change in the level of expression of the Pk-1 locus and 
also, as it is derived from C3H, it has a tissue specific structural 
difference in the PK-L isoenzyme compared to that of C57BL/6 liver. 
Analysis of this phenotype is the subject of Chapter 7. 
5.3 Conclusions 
The following conclusions can be drawn (Table 5.6). 
Of the phenotypes immunologically characterised, two show altered 
levels of enzyme. These are SWR, which has a tissue specific decrease 
in PK-L in the liver, and MTJN, which shows a systemic increase in the 
concentration of PK-R and PK-L. A third phenotype of particular 
interest is C3H/He which shows a tissue specific structural gene 
mutation, this will be discussed in Chapter 7. The other phenotypes 
have all been shown to be structural mutations. 
It has also been shown that the activity variation in liver is not 
correlated to the liver PK-M2 isoenzyine activity, confirming that these 
phenotypes are controlled by the Pk-1 locus and not the Pk-3 locus. 
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CHAPTER 6 
ANALYSIS OF A TISSUE SPECIFIC LOW LIVER PK CONCENTRATION 
PHENOTYPE (SwR) 
6.1 Introduction 
In the previous chapter, (5), two of the phenotypes analysed by 
immunoprecipitation had altered numbers of enzyme molecules. The 
inbred strain SWR had a decrease in the number of enzyme molecules in 
the liver, whilst the MUN phenotype had an increased number of enzyme 
molecules in both liver and blood. The SWR phenotype will be discussed 
further in this chapter and the MUN phenotype in Chapter 7. 
The low liver PK activity in SWR animals was discovered during the 
screening of inbred and wild caught mice for activity variants of 
glycolytic enzymes (Bulfield et al., 1974., 1983). It is an unusual 
phenotype, as the low activity is tissue specific with only the liver 
enzyme being affected. The differential expression of the Pk-1 gene 
in liver and blood can be investigated using this tissue specific 
mutation. 
Results obtained by immunoprecipitation (Chapter 5) have shown 
that the numbers of enzyme molecules are altered, not enzyme 
structure. The increased intercept (Fig. 6.1) indicates a decrease in 
the number of enzyme molecules in the liver. The blood PK of the SWR 
phenotype appears to be identical to the blood PK of C57BL/6 (Fig. 
















Increasing volume of enzyme 
with fixed level of antibody 
FIGURE 6.1. 
Immunoprecipitation of PK-L from the liver of C57BL/6 and SWR 
animals. Summarised from Figure 5.1. 
Intercept 	Slope 
C57BL/6 	1.35 + 0.13 19.8 + 0.1 







Increasing volume of enzyme 
with fixed level of antibody 
FIGURE 6.2. 
Immunoprecipitation of PK-R in blood from C57BL/6 and SWR animals. 
Summarised from Figure 5.2. 
Intercept 	Slope 
C57BL/6 	 1.85 + 0.1 20.1 + 1.3 
SWR 	 1.76 -i- 0.08 	18.9 + 0.5 
A segregation analysis of SWR with C57BL (subline unknown) has 
previously been carried out (Moore, 1981) (Fig. 6.3) and biochemical 
analysis could not detect any structural differences (Table 6.1). 
Linkage to agouti (a) and albino (C) was tested and no linkage 
found (Moore, 1981). 
Analysis of the F 2 data implied a single gene difference which 
behaved additively. This would be the expected result from both a 
structural gene mutation or a mutation in a cis-acting regulatory 
gene. 
Segregation of 2 alleles in an F 2 cross produces three peaks in a 
1:2:1 ratio. In the F2 data (K.J. Moore, personal communication, see 
Fig. 6.3) the division between the three groups was not unequivocal. A 
backcross with F 1 animals to the parents produces 2 groups in a 1:1 
ratio which is easier to interpret. It was therefore decided to repeat 
the segregation by backcrossing F 1 animals to both parents. 
6.2 Segregation analysis 
As PK from the blood of SWR animals and C57BL/6 animals has the same 
structure and number of enzyme molecules, no segregation was expected 
and none was found (Fig. 6.4). The data from liver however presents 
several problems. The F 1 data does not lie between the parental means 
as was found in the previous segregation. The mean of the F 1 is almost 
the same as that of the SWR parents (Fig. 6.5), suggesting either 
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Segregation analysis of c57BL and SWR. 
parental and F 1 results are from the present study. Specific 
activity of pyruvate kinase was measured on a 1/10 dilution of a 10% 
homogenate. 
The F2 data, using an unknown C57BL subline was by K.J. Moore 
(personal communication) with additional data from the present study. 
One square equals one animal. 
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TABLE 6.1. Chemical analysis of liver PK-L from C57BL and SWR. 
(Reprinted from K.J. Moore, 1981) + S.E. 
CC57BL 	 SWR 	 Ratio 	(p) 
SWR/C57BL 
KPEP 	48.25 ± 0.55 	48.67 + 10.3 	1.0 	N.S. 
K in ADP 
	327.0 + 22 	308.0 + 9.46 	0.94 	N.S. 
- 	 - 
V max 	 60.5 + 4.11 	36.84 + 13.5 	0.61 	0.001 - 	 - 
Heat Stability 	- No detectable difference 
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Specific activity (mUnits ml-1) 
FIGURE 6.4. 
Segregation analysis of C57BL/6 and SWR, backcross data from 
the blood. One square equals one animal. 
LIVER 
Number 
of animals 	SWR 	PARENTAL STRAINS 
Specific' activity (mUnits mg 1 wet wt.) 
FIGURE 6.5. 
Segregation analysis of C57BL/6 and SWR; 	Backcross data from 
liver. Each square represents one animal. 
suggested by the earlier data), interaction with other genes or 
"noise" arising from the different genetic backgrounds of the parental 
strains. This is a common phenomenon in crosses looking at enzyme 
activity as the final activity phenotype can be affected by many 
parameters. A similar pattern is seen with the backcross to SWR (Fig. 
6.4). The animals do not segregate into two groups but fall into a SWR 
phenotype. The backcross to C57BL/6 does however segregate into two 
groups, one with the C57BL/6 phenotype, the second group into an F 1 
phenotype, although the mean is higher than the actual F 1 animals. Nor 
is the distribution 1:1 as should be expected but 2:1 (Fig. 6.4, Table 
6.2). If there was a single gene difference with dominance of the SWR 
phenotype, the C57BL/6 backcross should have produced 2 groups, one 
with an SWR phenotype and one with C57BL/6 phenotype. Therefore the 
two sets of backcross data do not appear to be consistent with one 
another, nor are they consistent with the previous F2 data. The 
subline of the C57BL animals in the F2 segregation was unknown but is 
possibly a different subline to C57BL/6 as suggested by its specific 
activity, which is different to that of C57BL/6 (Table 6.3), and 
although it is possible that this may contribute to the different 
segregation there is no evidence to suggest that this is the case and 
genetic differences are probably minimal. 
TABLE 6.2 Mean specific activities from F 1 animals backcrossed 
to SWR and C57BL/6 
Specific Activity 	fl 
(m Units mg- 
1 
 wet wt) 
+ S.E. 
SWR 35.3 + 1.45 14 
C57BL/6 82.0 ± 2.8 28 
F 1 40.25+ 2.5 20 
Backcross to SWR 35.7 + 2.3 45 
BackcrosS to C57BL/6 	low group 52.85+ 2.1 28 
high group 92.14+ 1.8 14 
TABLE 6.3 Specific activities of sublines of C57BL, SWR and 
C57L 
Specific Activity (m Units mg-1 wet wt) + S.E. 
Moore, 1981 	 Present study 
C57BL (unknown) 
	
66.85 + 2.47 
C57L 
	
57.97 + 4.9 
	
56.5 + 1.45 
C57BL/6 
	
82.0 ± 2.8 
SWR 
	





Six recombinant inbred strains between C57L and SWR (SWxL) were 
obtained (B. Taylor, Jackson Laboratory). These were assayed for liver 
PK activity to determine if they were segregating for a single gene 
difference. A third C57 strain (C57L) was the progenitor strain for 
these RI strains but as far as can be determined (Table 6.3) the 
genetic differences at Pk-1 are minimal between this strain and 
C57BL/6. 
6.3 Recombinant inbred strains (RI strains) 
Recombinant inbred strains are powerful tools for the analysis of 
linkage and the segregation of genes. 
RI strains are derived by crossing two inbred strains which are 
well characterised genetically. This is followed by a period of 
further inbreeding as follows: 
Strain A 	x 	Strain B 
'I 
F 1 1 
Inbreeding 
AXB-1 	AXB-2 ' 
Brother/sister matings from the F 2 generation are inbred until all 
the genes once more approach homozygosity. Each strain originally has 
a random assortment of A and B alleles at each locus. During 
subsequent inbreeding each locus becomes fixed for the a or b 
allele in a random manner. If a difference is observed between the two 
progenitor strains, and this is due to a single gene difference, then 
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50% recombinant strains will be of the A phenotype and 50% of the B 
phenotype. If the gene is closely linked to another gene segregating 
between the two strains, then they will cosegregate amongst the inbred 
strains and have the same distribution pattern throughout the strains. 
Loosely linked genes will have similar patterns but with crossovers 
between some of the RI strains. Recombination frequency is estimated 
by the equation r = R/(4-6R). R = observed fraction with recombinant 
genotypes. In general only relatively close linkage (< 12 
centimorgans) is detected using RI strains (Taylor, 1981). If the 
variation being investigated cosegregates with a second gene, linkage 
can be assumed. 
Thus cosegregation with a gene whose map position is known allows 
the map position of the gene being investigated to be calculated. RI 
strains can therefore be a useful mapping tool if the strain 
distribution pattern of marker genes is known, the greater the number 
of known SDP's, the greater the power to test linkage. 
The six SWXL RI strains available were assayed for liver PK 
activity. Three had a PK activity, not statistically different from 
C57L, and three not different from SWR (Fig. 6.6, Table 6.4). The six 
strains fall into two non-overlapping groups, although the standard 
errors for the C57L type strains are high and the strain SWXL- 12 has 
a mean nearer to the SWR mean than would be expected. The data does 
however show that the strains segregate into two groups indicating the 
presence of a single major gene. The high standard errors for C57L 
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Analysis of six recombinant inbred strains derived fi'om 
57L 	and SWR; 	specific activity of PK-L from liver. Each 
square represents one animal. 
Strain 	 Specific activity 
C57L 	 56.5 + 2.5 
SWR 35.3 	1.1+5 
The results are analysed statistically in Table 6.4. 
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background also acting upon PK activity. 
Thus, although the data indicates a single major gene, the 
possibility of a polygenic background also affecting PK activity 
cannot be ruled out. 
6.4 Mathematical analysis (Elston, 1984) 
To further clarify the situation, the data was sent for analysis to Dr 
R. Elston, Louisiana State University Medical Centre, New Orleans, 
U.S.A. who has developed a mathematical analysis of segregation data 
based on a maximum likelihood method. The method and analysis of the 
segregation data for SWR x C57BL/6 is given in Appendix A. 
Dr Elston concludes from his analysis, that the hypothesis most 
compatible with the data is one in which two linked loci are 
segregating. However the recombination frequency for this hypothesis 
is 0.89 which is biologically unrealistic. The next best hypothesis is 
one in which both a major gene and polygenes are segregating - the 
"mixed model". However, there is a significant departure from the 
"mixed model" due to the lack of segregation in the backcross to SWR 
and the displaced mean of the F 1 which cannot be explained. 
To conclude, the data from the segregation analysis and the 
recombinant inbred strains, taken together, is consistant with the 
segregation of a single gene. This, however, needs to be confirmed by 
further genetical analysis using biochemical variables or molecular 
markers (R.F.L.P.$) for the Pk-1 locus. 
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Table 6.4. Statistical analysis of the 6 SWXL RI strains with respect 
to liver PK activity 
Specific Activity 
(m Units mg-1 wet wt.) + S.E. 
Group 1 	 Group 2 
SWXL-4, 38.0 ± 0.9 SWXL-12, 52.8 + 	1.9 
SWXL-16, 35.0 + 	1.0 SWXL-17, 61.0 + 3.0 
SWXL-15, 35.6 ± 	1.9 SWXL-14, 61.3 1- 	2.3 
SWR 35.3 + 	1.45 C57L 56.5 -4- 	1.45 
6.5 Linkage of the SWR phenotype to the structural gene 
If the SWR phenotype is due to a single gene difference, as indicated 
by the above data, does it map close to the structural gene? The 
answer to this question is important in discussing possible modes of 
action. Linkage could be detected by cosegregation of an allele of the 
structural gene with the activity difference. However, to date no such 
structural difference has been observed as discussed in section 6.1. 
An electrophoretic variant, Pk_lS,  is however observed in the 
species Mus spretus 	 . Attempts were made to cross this 
allele into C57BL/6 thus introducing the Pk-1 5 allele into an 
inbred strain allowing linkage of the SWR, C3H and MUN phenotypes to 
the structural gene to be determined. Electrophoretic mobility was 
74 
measured using isoelectric- focusing gels (3.2.5). The gels were 
stained for PK activity and visualized under UV lights (3.2.6). 
Crosses were first made with Mus spretus (referred to as MS) and CBA 
as there are fewer infertility genes operating in this cross than in 
one to C57BL/6. CBA x MS. F 1 animals with the electrophoretic variant 
were then crossed to C578L/6. 
Few offspring were produced from the cross CBA x MS. Of these two 
had the electrophoretic variant 	 . Unfortunately it proved 
impossible to produce offspring with these two animals either crossed 
to CBA or crossed to C57BL/6, therefore, because of the limited time 
available, this breeding programme was abandoned. Another approach to 
finding structural differences is to look for restriction fragment 
length polymorphisms. This approach is discussed in Chapter 10. 
6.6 Conclusions 
In conclusion, the SWR phenotype is tissue specific with a decrease in 
number of enzyme molecules in the liver. There is some evidence from 
the segregation data that the SWR phenotype may be dominant. However 
the unusual backcross results could also arise-from the affects of 
modifier genes or be due to "noise" arising from the different 
genetical backgrounds of the parental strains. Data from RI strains 
and from a mathematical analysis of the segregation data suggest that 
the variation is due to a major single gene effect segregating on a 
polygenic background, but the possibility also exists that it may be 
due to the segregation of two linked loci. The interaction of this 
tissue specific regulatory mutation, with the systemic regulatory 




Analysis of the C3H/He and MUN phenotypes 
7.1 Introduction 
The immunological characterisation described in Chapter 5 showed two 
further phenotypes, other than the SWR phenotype, to be of interest. 
The C3H/He phenotype has a tissue specific alteration in the 
structure of liver PK when compared with C57BL/6, whilst MUN has a 
systemic increase in the number of enzyme molecules in liver and blood 
(Figs. 7.1, 7.2 and Table 7.1). The MUM phenotype arose during 
mutagenesis experiments, using 1- ethyl- 1 -nitro sourea as the mutagen, 
o 
	
	 \c Biochemical and genetical analysis showed it to be a 
single gene mutation and to have no observable structural differences 
to the enzyme from C3H animals in either liver or blood (Charles & 
Prestch, 1984). 
First, the C3H/He phenotype was analysed by using the BXH 
recombinant inbred strains, which are derived from C57BL/6J and C3H/HeJ 
(B. Taylor, 1981), to determine if the difference was due to a single 
gene. 
Increasing volume of enzyme 
FIGURE 7 . 1. 
ImmunoprecipitatiOn analysis of PK-L in C3H/He, MIJN and C57BL/6 
livers. Summarised from Figure 5.1. 
Intercept 	Slope 
C57BL/6 	 1.35 + 1.3 19.8 + 0.9 
C3H/He 107 + 0.17 	8.37+ 0.8 










Increasing volume of enzyme 
WT(t1PF 7.2. 
ImmunopreciPitatiofl analysis of PK-R from C3H/He, MUN and C57BL/6 
blood. Summarised from Figure 5.2. 
Intercept 	Slope 
7BL/6 	 1.85 + 0.1 20.1 + 1.3 
C3H/He 2.15 	0.15 	17.4 	
1.8 
MtJN 	 0.85 T 0.05 38.5 2.1 
TABLE 7.1 Specific activities of C3H/He, MUN and C57BL/6 in 
liver and blood 
Phenotype Specific Activity + S.E. 
Liver Blood 
ug 1 (mUnits mg- 1 wet wt) (mUnits ml- 1 
C57BL/6 82.0 ± 2.8 7.58 + 0.17 
C3H/He 42.8 + 2.4 7.52 + 0.20 
MUN 100.7 + 4.4 16.88 + 0.32 
Second, linkage of the MTJN phenotype to the structural gene was 
tested by segregation from the W phenotype, which is homozygous for the 
Pk- lb allele in liver and blood (Moore & Bulfield, 1981). 
Unfortunately the Pk_lb allele also affects activity, making 
segregation analysis more difficult. Ideally an allele of the Pk-1 
gene not affecting activity would be preferable. Unfortunately 
attempts to cross the electrophoretic variant from Mus spretus into 





7.2 • 1 The C3H/He phenotype 
The ixnmunoprecipitation results showed that C3H/He and C57BL/6 had the 
same slope (i.e. specific activities) and intercept in the blood. 
Therefore in blood there is the same number of enzyme molecules in 
each strain, and each molecule has the same V max • In liver. 
homogenates however, the intercepts are the same indicating the same 
number of molecules, but the slopes (i.e. specific activities) are not 
(Table 7.2). 
TABLE 7.2 Immunoprecipitation analysis of C3H/He and C57BL/6 
showing the relationship between intercepts (inversely 
proportional to enzyme number) and slopes (proportional to 
specific activity) when a fixed amount of antibody is used 
(3.2.8) 
LIVER 
Intercept + S.E. 	 Slope + S.E. 
C57BL/6 	 1.35+0.13 	 19.8+0.9 
C3H/He 	 1.07+0.07 	 8.37+0.8 
BLOOD 
C57BL/6 	 1.85+0.10 	 20.1 +1.3 
C3H/He 	 2.10+0.15 	 17.4+1.8 
The lower slope of the liver PR extracted from C3H/He, reflects its 
decreased activity. As C3H/He has the same number of enzyme molecules 
as C57BL/6, the V max 
 of the molecules must be lower. The activity 
difference between C3H/He and C57BL/6 liver PR is therefore due to a 
structural alteration in the liver PR protein. Activity of 12 BXH RI 
strains was measured to determine if the difference segregated as a 
single gene. Three strains had C57BL/6 activity and 8 strains C3H/He 
activity (Table 7.3). The two groups were non-overlapping. The twelfth 
strain BXH-14 was a problem. Two vials of liver labelled BXH-14 
arrived. In the first vial the livers all assayed as C3H/He. In the 
second vial they all assayed on C57BL/6. Presumably one was 
mislabelled. Therefore no result for BXH-14 is included. The BXH RI 
strains do, however, fall into two distinct groups with activities 
equivalent to the progenitor strains, but they do not show a 1:1 
pattern as expected for a single gene effect. Instead they show a 1:2 
pattern, or possibly 1:3. Two interacting genes could produce a 1:3 
pattern if one mutant allele was necessary for the effect to be seen. 
As only 11 BXH strains were available, it is not possible to say which 
of these two effects is occurring. A larger number of strains would be 
required to clarify the situation. It is possible however to say that 
at least one major gene is involved. 
78 
The final structure of liver PK-L but not blood PK-R is altered in 
C3H/He mice. Although both are coded for by the Pk-1 gene, it can be 
TABLE 7.3 Liver PK-L specific activity in BXH recombinant 
inbred strains 
Strain 	PK activity .(mU mg  
wet wt.) + S.E. 
C57BL/6J 	57.0 + 2.8 	 B 
C3H/J 	 36.6 ± 1.1 	 H 
BXH 2 37.1 + 1.4 	 H 
BXH 3 38.4 + 2.0 	 H 
BXH 4 37.4 + 4.4 	 H 
BXH 6 80.3 + 1.7 	 B 
BXH 7 35.3 + 3.0 	 H 
BXH 8 68.8 + 3.5 	 B 
BXH 9 60.1 + 1.7 	 B 
BXH 10 38.5 + 2.5 	 H 
BXH 11 43.1 ± 1.5 	 H 
BXH 12 42.5 + 3.5 	 II 
BXH14 - 
BXH 19 35.0 + 0.7 	 H 
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assumed that the mutation occurs in the exon which is unique to PK-L 
(Fig. 7.3). This could be due to a mutational event such as a base 
change which would affect the final amino acid sequence. It is also 
possible that splicing sequences or termination sequences may be 
effected, again resulting in a mutated protein with altered V. 
max 
The DNA sequences or amino acid sequences of the proteins will be 
necessary to clarify the problem. 
All the evidence so far is consistent with a single gene mutation 
at the structural gene Pk-1. This has been called Pk-1 1 . 
7.2.2 The MtJN phenotype 
The immurioprecipitation results show an increase in the number of 
enzyme molecules, in both liver and blood, when compared with C3H/He 
and C57BL/6 animals (Figs. 7.1, 7.2). For both liver and blood the 
slope for MUN animals is 2-fold that for C3H/He animals which, 
suggests the possibility of 
a duplication event having occurred. 
When the specific activity of MUN was first compared to C57BL/6 it 
appeared to be a tissue specific increase in PlC activity. This is 
because the structural mutation in C3H liver PlC is also carried by MUN 
liver PlC. The structural gene muation decreases V 
max 
 by 2-fold 
which compensates for the 2-fold increase in enzyme molecule number 
(Table 7.1). 
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The MUN phenotype had previously been shown to segregate as a 
A mutational event occurring 
in the excluded exon will not 
effect PK-R 
1— 	4% 44 
M2  
3 , 
Exon 	11 	10 	9 	8b 	8a 	7 	6 	5 	4 	5' 
FIGURE 7.3. 
A representation of the exon arrangement 
in Pk-1. 
single gene difference (Charles & Prestch, 1984) with C3H/J. The 
relationship of the gene causing the MUM phenotype to the structural 
gene was investigated by segregation analysis of MUN with W(Pklb/ 
Pk- lb). 
Analysis of cross MUM x W 
The W phenotype has the Pk_lb  structural gene which lowers V max 
and heat stability of liver and blood PK. It also has C57BL/6 levels 
of enzyme molecules. The MUM phenotype has the Pk-1 1 allele of 
the structural gene and increased enzyme number. Enzyme molecule 
number for the F 1 generation was measured by immunoprecipitation (Fig. 
7.4). An increased number of molecules was seen but the errors were 
much larger than for the parental strains, both for intercept and 
slope. The F 1 activity appears to be codominant in blood but in liver 
the intercept is displaced towards the W phenotype. In the backcrosses 
the animals segregate into two groups, high activity (high enzyme 
molecule number) and low activity (low enzyme molecule number) (Figs. 
7.5, 7.6). The structural relationships were determined by measuring 
the heat stability of the enzymes from each animal (Table 7.4). These 
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FIGURE 7.4 	
1 	1 	b 	b 
Imxnunoprecipitation of MUN (Pk-1 /Pk-1 ), W(Pk-1 /Pk-1 
and F animals in blood and liver using anti PK-L antiserum. The 
methoA was that described in Section 3.2.8. The error bars shown the 
standard error of each point as calculated using linear regression. 
Number of animals (n) = 5 
each assayed in triplicate 
TABLE 7.4 Heat Stabilities of parental, F 1 and backcross animals 
in the segregation of w(pk_lb/pk_lb) and 
Mun(Pk_1/pk-11).(520c for 1 hour.) 
STRAIN BLOOD 	 LIVER 
Percentage Percentage 
residual activity 	residual activity 
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MUN 8.1+0.3 
W 26.6 + 1.0 
MtJNxW, F1 13.6 + 0.9 
Backcross to W high 
activity group 17.4 + 1.9 
Backcross to W low 
activity group 25.0 + 1.6 
Backcross to MUN 
high activity groull 	8.0 + 1.1 
Backcross to HUN 
low activity group 	9.5 + 1.1 
24.2 + 
8.0 :t. 0.9 
35.5 • 1.5 
23.3 :!: 1.9 
10.3 ;!: 0.9 
19.5 ± 1.5 
23.1 + 1.8 
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FIGURE 7.5. 
Segregation analysis of MUN (Pk_lh/Pk_lt) with  W(Pk_lb/Pk_lb). 
The average heat stability of each group in the backcross 
was measured (Table 7.3) the dotted line indicates the 
line chosen as dividing the backcrosses into parental or 
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FIGURE 7.6. 
Segregation analysis of MUN (Pk-1 t/PR_iL)  with  W(Pk_ib/Pk_ib) 
in blood. The average heat stability of each group in the 















Immunoprecipitations were not done for each animal as it was felt 
that the information produced would be very complex to analyse, as the 
great variability found in the F 1 animals would also be expected to be 
seen in the backcross animals. The heat stabilities of the parental 
strains showed that MUN as well as W has a heat labile enzyme in 
both liver and blood. However the differences between the MUN and W 
enzyme lability was still great enough to allow segregation analysis. 
It should also be noted that in blood the NUN enzyme is the most 
heat labile, whilst in liver the W enzyme is the most heat labile. The 
results also indicate a structural gene difference between the blood 
enzymes of MUN and C57BL/6 which were not reflected in the earlier 
immunoprecipitation results (Chapter 5). 
The percentage residual activity for parental, F, and backcross 
animals is given in Table 7.4. The backcross data was derived by 
averaging the residual activities in each of the activity groups into 
which the animals had segregated (Figs. 7.5, 7.6). 
The data indicates that there may be linkage of the MUM regulatory 
phenotype to the structural gene. In blood, low heat stability appears 
to cosegregate with high activity (MUN type) animals, whilst higher 
heat stability appears to cosegregate with the W type animals. 
The reverse is seen to some extent in liver. The cosegregation is 
not absolutely clear and there were some animals which appeared to 
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show recombination between the structural and regulatory loci. However 
the parameters being observed have only a two-fold order of magnitude 
difference, are very variable and both affect the phenotypic activity. 
Thus the fact that some degree of cosegregation is observed is 
indicative of some degree of linkage. The results are consistant with 
those obtained for the cross MTJN x C57BL/6 (Chapter 8). 
To determine closeness of linkage, a structural gene mutation is 
required which does not affect enzyme activity such as an 
electrophoretic variant, but as described in Chapter 6.5 attempts to 
cross such a variant into C57BL/6 failed. It will therefore be 
necessary to screen the MtJN phenotype along with the phenotypes with 
normal enzyme levels for restriction fragment length polymorphisms as 
described in Chapter 10. The segregation analysis can then be repeated 
classifying each animal as MUN or otherwise with respect to it's RFLP. 
7.3 Conclusions 
To conclude, the C3H phenotype has been shown to have a tissue specific 
structural gene mutation resulting in a decrease in the V 	of 
max 
C3H liver PK-L. Conventional segregation analysis of C3H and C57BL/6 
liver PK-L activity would be difficult as only a two-fold difference 
is observed and the groups almost overlap. 
Segregation analysis using the BXH recombinant inbred strains 
however, has indicated the presence of a single gene difference 
(although the possibility of two genes being involved cannot be 
disregarded entirely). Assuming the difference is due to a single 
gene, the C3H allele has been named Pk-1 1 . 
The MtJN phenotype has been shown to have a systemic increase in 
the number of enzyme molecules. Segregation from w(Pk.11)/Pk_lb) 
indicated a single gene difference affecting enzyme number, this was 
reflected by the observed activity. Cosegregation of heat stability 
with the putative regulatory gene indicates putative linkage of the 
structural gene and the regulatory gene. Although there is some 
indication of possible recombination, this could not be accurately 
determined due to the variability of the effects being investigated. 
Inheritance of the MUN phenotype appeared to be codominant. 
Segregation analysis of MUN with SWR was also carried out to 
determine interaction between the regulatory effects found in these 
strains. The data is discussed in Chapter 8. 
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FURTHER ANALYSIS OF THE SWR AND HUN PHENOTYPES 
8.1  Introduction 
In Chapters 6 and 7 the SWR and HUN phenotypes, which had been 
identified as possible regulatory mutations (Chapter 5) were analysed 
genetically by crossing to C57BL/6 and W(Pk_lb/Pk_lb) respectively. 
Analysis of a structural gene mutation present in C3H and MUN 
phenotypes was also carried out using recombinant inbred strains 
derived from C3H and C57BL/6. 
In Chapter 6 it was concluded that the SWR phenotype was caused by 
a tissue specific regulatory gene mutation affecting only the 
concentration of the liver enzyme and was most likely due to a single 
major gene, but with modifier genes affecting expression in certain of 
the crosses. 
It was also concluded in Chapter 5, that the HUN phenotype was 
caused by a systemic regulatory gene mutation affecting enzyme number. 
Biochemical analysis of the MUN and C3H phenotypes by immuno 
precipitation with anti-PK antiserum, and genetical analysis of the BXH 
recombinant inbred strains showed both MUN and the strain \2e which it ts 
CM, to be carrying a structural gene mutation resulting in a 
decrease in the specific activity of the PX-L isoenzyme only when 
compared to C57BL/6. The C3H and MUN phenotypes therefore both contain 
a tissue specific structural gene mutation; the MUN phenotype has, in 
addition, a systemic regulatory gene mutation increasing enzyme 
number 2-3 fold in both liver and blood. 
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Several points must now be considered further: 
Does the MUN phenotype segregate from C57BL/6 as a single gene? 
How do the MUN and SWR phenotypes interact and are they alleles of 
a single gene? 
The following crosses have already been analysed: 
C3H x MTJN (Charles and Pretsch, 1984). 
SWR x C57BL/6 (Chapter 6). 
C3H x C57BL/6 (Using BXH recombinant inbred strains, Chapter 7). 
MUN x W(Pk_lb/Pk_lb) (Chapter 7). 
To complete the genetical analysis of these phenotypes, the 
following crosses were made and the results are presented in this 
Chapter: 
MUN x SWR. 
MUN x C57BL/6. 
In blood, PK from C3H, SWR and C57BL/6 is structurally 
indistinguishable when biochemical and immunological evidence is 
considered and has the same enzyme concentration. The observed 
activity differences between MUN and its progenitor strain C3H can be 
solely accounted for by the difference in intercept (enzyme 
concentration) when immunoprecipitated with PK-L antiserum. Thus the 
MUN enzyme appears to be structurally the same as C3H. Therefore in 
the segregation analysis of crosses 5 and 6 only interactions of the 
regulatory genes affect blood PK activities. 
In liver the situation is more complex. Structural differences 
exist between the C3H (and hence MUN) enzyme and that found in SWR and 
C57BL/6, therefore in crosses between MUN and either SWR or C57BL/6, 
the results are complicated by the segregation of genes affecting both 
enzyme activity and enzyme concentration. Indeed, if the regulatory 
gene mutations in MtJN and SWR are non-allelic, this cross may involve 
segregation of three different genes. 
8.2 Results 
8.2.1 Cross 5, WiN x SWR 
In the cross between the MUN and SWR phenotypes, interactions of their 
regulatory gene mutations can be observed. In blood, PK from both 
strains is structurally indistinguishable, therefore the crosses only 
involve interactions between the regulatory genes. In the liver the 
structural gene differences between the SWR enzyme and the MUN enzyme 
must also be considered. 
The MUN regulatory gene mutation was shown to act codominantly in 
the F 1 of a cross to C3H (Charles and Pretsch, 1984). As P1( in the 
blood of C3H and SWR is indistinguishable, similar results would be 
expected in the MtJN x SWR cross. 
Immunoprecipitation of F 1 animals and parental animals from this 
cross showed the F 1 to have an intermediate number of enzyme molecules 
in both blood and liver (Fig. 8.1). The observed PK activity (Table 
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FIGURE 8.1 	
i 	i 	 a Iminunoprecipitation of MUN (Pk-1 /pk-1 ), swR(Pk-1 ,Pk_la)  and 
F 1 animals in blood and liver using anti PK-L antiserum. The method 
was that described in Section 3.2.8. The error bars shown the 
standard error of each point as calculated using linear regression. 
Number of animals (n) = 5 
each assayed in triplicate 
Table 8.1. Specific activities of pyruvate kinase in the liver 
and blood of parental and F 1 animals. 
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Specific Activity + S.E. 
Blood Liver 
(mUnits m1 1 ) (N) (munits mg wet wt) (N) 
16.7 + 0.3 (41) 101.0 + 4.4 (22) 
8.6 + 0.3  35.3 + 1.5 (14) 
7.6 + 0.2  82.0 ± 2.8 (28) 
12.65 68.2 
15.3 	+ 1.0 (10) 97.4 + 4.6 (10) 
12.15 92.5 - 





(MUN x SWR)F 1 
expected 
observed 
(MUN x c57BL/6 
expected 
observed 
fl = Number of animals. 
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expected for codominance, however this may be due to other factors 
deriving from the different genetic backgrounds of the parental 
animals (such as modifier genes which have previously been shown to 
segregate with the SWR phenotype, Chapter 6). The data are, however, 
consistent with SWR and MUN segregating codominantly both in blood, 
where the SWR regulatory gene mutation has no phenotypic affect, and 
in liver where the SWR regulatory gene mutation produces a decrease in 
enzyme number. 
The SWR phenotype has been shown to be due to a single regulatory 
gene mutation (Chapter 6) as has the MUN phenotype (Chapter 7), but it 
has not yet been determined whether or not they are allelic. 
PK activities in the liver of F 2 animals of a MUN x SWR cross show 
segregation into three groups (Ratio 11:20:9, Fig. 8.2b) and possible 
segregation in the blood (Ratio 14:31:14, Fig. 8.2a). There could be 
up to three genes affecting liver PK activity in this cross: 
The structural gene. 
The regulatory gene carrying the SWR mutation. 
The regulatory gene carrying the MUN mutation. 
It has been shown that the MUN regulatory gene is linked to the 
structural gene (Chapter 7) and thus they will segregate together in 
the cross. The segregation observed is that expected of alleles of a 
single gene, or of two tightly linked genes (expected Ratio 10:20:10, 
observed ratio 11:20:9). Thus it can be concluded that the regulatory 
gene in the SWR and MUM phenotypes are allelic or linked in such a 
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FIGURE 8.2 
The F2 generations for the cross MUN x SWR in the liver and blood. 
Pyruvate kinase activity was measured on a 10% blood lysate or a 1/10 
dilution of 10% liver homogenate. 
One square equals one animal. Each animal was measured in 
triplicate. 
manner that they behave in crosses as alleles. Also, since the MUN 
regulatory gene is linked to the structural gene, Pk-1 (Chapter 7) 
then the SWR regulatory gene must also be linked to Pk- 1. 
The results obtained from backcrosses of the F 1 animals to the 
parental strains did not produce such clear results as the F 2 data. A 
backcross involving a single gene difference would be expected to fall 
into two groups of equal number, one with the parental phenotype and 
one with the F 1 phenotype. 
In the blood (Fig. 8.3) no evidence of segregation was observed in 
backcross animals. Also, some animals had very high PK activity 
(marked by a cross, Fig. 8.3) outside the variation observed in 
parental or F 1 animals (Table 8.1). Animals with PK activities outside 
previously observed variation were also seen in the backcross results 
derived from liver (Fig. 8.4). The results in liver could be explained 
by recombination, but this would indicate that the structural locus 
and regulatory locus were not tightly linked, however recombination 
could not explain the high enzyme activity seen in the blood of some 
animals. The backcross to SWR is particularly unusual as there appears 
to be a displacement towards the SWR phenotype. This was also observed 
in the SWR backcross to F 1 animals in the C57BL/6 x SWR cross (Chapter 
6). Modifier genes may be responsible for some of these unusual 
results. 
Summary from Cross 5 - MUN x SWR 
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FIGURE 8.3 
Backcrosses of (MUM x SWR) F animals to the parental strains MUM and 
SWR in blood. 
Pyruvate kinase activity was measured on a 10% blood lysate. Each 
animal was assayed in triplicate. 
One square equals one animal. 
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FIGURE 8.4 
Backcrosses of (MTJN x SWR) F 1 animals to the parental strains MtJN and 
SWR in the liver. 
Pyruvate kinase activity was measured on a 1/10 dilution of a 10% 
liver homogenate. 
One square equals one animal. Each animal was measured in 
triplicate. 
(2) In the F2 cross SWR and MUM behave as alleles of a single 
regulatory gene linked to Pk-1. 
8.2.2. Cross 6 MUN x C57BL/6 
The final cross to complete the genetic analysis of this system is MUM 
x C57BL/6. MUM differs from C57BL/6 by a single regulatory gene 
mutation in the blood. The liver is complicated by the effect of the 
tissue specific structural gene mutation in WiN (from the C3H parental 
strain, see Chapter 7) which reduces the observed activity in such a 
way that the activities of the parental strains are too close for 
clear segregation analysis (Table 8.1). The observed activity does not 
however affect the intercept in immunoprecipitation and therefore this 
method reveals the interaction of the regulatory genes. The F 1 data 
from immunoprecipitation in the liver shows MUM and C57BL/6 to be 
codominant (Fig. 8.5). This is in agreement with the data from MUM x 
C3H and MUM x SWR crosses. The intercept in F, animals in blood lies 
between MUM and C57BL/6 but is displaced towards the MUM parental 
intercept more than expected (Fig. 8.5, Table 8.2). However, the data 
taken as a whole is consistent with a codominant effect. 
The liver PK data from the F 2 cross was expected to reveal little 
information due to the closeness of the actvities of the parental 
strains (Fig. 8.6b). However some evidence of segregation can be 
observed. There appear also to be some animals of unusually low 
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FIGURE 8.5 	 i 
Immunoprecipitation of MUN (Pk-1 /Pk-1 1 ), C57BL/6 and 
F 1  animals in blood and liver using anti PK-L antiserum. The method 
was that described in Section 3.2.8. The error bars shown the 
standard error of each point as calculated using linear regression. 
Number of animals (n) = 5 
each assayed in triplicate 
Table 8.2. The intercepts obtained on precipitation of the parental 
and F 1 strains with anti PK antiserum. 
Intercept u1 1 Strain 
Blood (10% (n) 	Liver (1/100 dilution (n) 
lysate) of 10% homogenate) 
MUN 9.0 ± 0.5 (5) 9.0 + 0.7 (5) 
SWR 21.0 ± 	1.0 (5) 38.0 + 0.6 (5) 
C57BL/6 22.0 + 	1.0 (5) 20.0 ± 2.0 (5) 
(MUNxSWR) F 1 observed 13.0 + 0.5 (10) 22.5 + 1.6 (10) 
expected 15.0 23.0 
(MUNxC57BL/6) observed 11.5 + 0.6 (10) 16.0 + 0.5 (10) 
F1 expected 15.5 14.5 
Note: The intercept is inversely proportional to the enzyme concentration. 
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FIGURE 8.6 
The F2  generation for the cross MUN x C57BL/6 in the liver and 
blood. 
Pyruvate kinase activity was measured on a 10% blood lysate or a 1/10 
dilution of 10% liver homogenate. 




to be a feature of many of these crosses and could be due to 
recombination of the MUN regulatory gene with the C57BL/6 structural 
gene, the effect of modifier genes or just "noise". The F 2 segregation 
in blood is unusual in that the MUN phenotypic group is represented by 
one animal only (Fig. 8.6a). The other two groups fall into the 
expected ratio of 1:2. There appears to be no explanation for this and 
it would appear unlikely that animals of the MUN phenotype are non-
viable. 
Again, because of the closeness of the parental enzyme activities, 
the backcross data was not expected to reveal much information. There 
is some evidence of segregation in the backcross to MtJN, but none in 
the backcross to C57BL/6 (Figs. 8.7 and 8.8). This was expected as the 
F 1 enzyme activities and C57BL/6 enzyme activity are very close. Once 
again there occurs a large number of animals outside the expected 
range of activities which, as in the case of the MUN x SWR cross, 
could be due to segregation of modifier genes. There is also the 
possibility that these animals may be recombinants. 
Summary 
The MUN and C57BL/6 phenotypes interact codominantly 
The segregation analysis is consistent with segregation of a 
single gene. 
Linkage of the regulatory gene to the structural gene Pk-1 is 
close but there are putative recombinants in the backcross which must 
also be considered. 
94 
of animals 	 c57BL/6 	F1 	f- MUN 
LIVER 
	
0 Backcross to Munich 
• Backcross to C57BL/6 
r1l1[i[iLILL __ 
30 	40 	50 	60 	70 80 	90 100 110 120 130 	140 	150 	160 	
170 	18C 
Specific activity (mUnits mg wet wt.) 
I_ 
BackcroSseS of (MUN x C57BL/6) F 1 to the parental strains in the 
liver. 
Pyruvate kinase activity was measured on a 1/10 dilution of a 10% 
liver homogenate. 
One square equals one animal. Each animal was measured in 
triplicate. 
i- of animals 
C5713L/6 	 F1 	 MiJN 
BLOOD 	 0 Backcross to C57BL/6 
• Backcross to Munich 
12 	13 	14 	15 	16 	17 	18 	19 	20 	21 	25 
Specific activity (mUnits ml -1 ) 
FIGURE 8.8 
Backcrosses of (MtJN x C57BL/6) F 1 to the parental strains in the 
blood. 
Pyruvate kinase activity was measured on a 10% blood lysate. Each 
animal was assayed in triplicate. 
One square equals one animal. 
8.3 Conclusions 
From the F, inununoprecipitatiOn data MUN appears to interact 
codominantly with C57BL/6 and SWR in both blood and liver. 
The segregation data is consistent with MUN and SWR phenotypes 
both being caused by single regulatory gene mutations which are linked 
to the structural gene. 
Outliers in the MUN x C57BL/6 backcrosses could, however, be 
possible recombinants between the structural gene and the regulatory 
gene. Alternatively these could be due to modifier genes segregating 
in the cross or just unexplained "noise". To clarify the situation a 
marker is required for the structural gene which does not affect 
enzyme activity, for example a restriction fragment length 
polymorphism (RFLP) (Chapter 10). The breeding of congenic strains 
carrying the mutation (that is strains in which the mutations have 
been crossed into the same genetic background to produce a series of 
inbred lines which differ only at the gene in question), would help to 
remove "noise" from the system caused by the different genetic 
backgrounds of the present strains (as has been done for - 
glucuronidase, Pfister et al., 1981). 
In the segregation MUN x SWR the mutations behave as alleles of a 
single gene. It is not, however, possible to distinguish genetically 
between alleles of a single locus or two tightly linked genes 
affecting the same activity. It may be possible to distinguish between 
these two possibilities using recombinant DNA techniques. 
summary 
The immunological behaviour and segregation analysis of the MUN 
and SWR phenotypes indicates that both are controlled by single gene 
mutations. 
The MUN and SWR mutations interact codominantly. 
MUN and SWR behave in crosses as alleles of a single regulatory 
gene and therefore, for simplicity, will be treated as alleles. 
Allelic designations are therefore: 
Structural gene 	Regulatory gene 
C57BL/6 	 Pk_l Sa 	 Pk,a 
MUN 	 Pk-1s 1 	 Pk-lr a-rn  




MAPPING OF THE Pk-1 LOCUS 
9.1 Introduction 
As discussed in Chapter 1, two tissue specific genes Pk-1 and Pk-3 
each code for two pyruvate kinase isoenzymes. Both have the capability 
of producing tissue specific messenger RNA by an exon exclusion 
mechanism (Noguchi et al., 1984) and both have high levels of 
homology at both DNA and amino acid levels (Saheki et al., 1982; 
Inoue et al., in press). These similarities raise interesting 
questions on the evolutionary relationship between these two loci. 
Homologous genes, i.e. genes coding for similar proteins, can arise in 
several ways. They can evolve separately by convergent evolution to 
produce orthologous genes (Lundin, 1979), an unlikely mechanism with 
Pk-1 and Pk-3 because of their similar molecular organisation, or 
by some form of duplication of the primordial gene after which each 
gene will follow its own evolutionary pathway to become paralogous 
genes (Lundin, 1979). This can have several consequences. The 
duplicate gene may be silent and become a pseudogene as is seen with, 
for example, the several haemoglobin pseudogenes 
(Leder et al., 1980), or it may evolve into a closely related but 
different enzyme, either with a closely related function or the same 
function but expressed differentially in a temporal or tissue specific 
manner. This seems to be the case with pyruvate kinase. 
Paralàgous genes can arise in two ways, either by tandem 
duplication resulting in both genes lying close together on the same 
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chromosome, or by tetraploidisation whereby chromosome number is 
duplicated at some stage in evolution. It is believed that at least 
two rounds of tetraploidisation have occurred during the evolution of 
mammals. However, in mammals the process of diploidisation (Ohno, 1970) 
followed tetraploidisation and replicate chromosomes as such are not 
observed. It is however possible to observe traces of ancient 
tetraploidisations in the chromosomes of some vertebrates. For example 
chromosomes 1, 7 and 9 in mouse and 1, 15 and 19 in Man (Lundin, 1979) 
If therefore Pk-1 and Pk-3 have arisen due to duplication by 
either tandem duplication or tetraploidisation, a starting point can be 
determined for mapping Pk-1 by considering the chromosomal position 
of Pk-3. Pk-3 has been shown to map to chromosome 9 using somatic 
cell hybridisation of Chinese hamster and mouse spleen cells with 
close linkage to Mpi-i (Peters et al., 1981) and linkage to Mod-1 
and dilute (d) (Johnson et al., 1980). 
Pk-1 has been shown to be unlinked to Pk-3 (Moore, 1981), thus 
is not likely to have arisen via tandem duplication but by 
tetraploidisation. Thus Pk-1 is likely to be on one of the 3 
chromosomes paralogous to chromosome 9; two of these have been 
identified as 7 and 1 (Lundin, 1979). Linkage to marker enzymes on 
these two chromosomes was carried out using the markers Hbb and 
Gpl-1 for chromosome 7 and Idh-1 for chromosome 1 (Moore, 1981). 
No linkage to the chromosome 7 markers was detected, but loose 
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linkage to Idh-1 was indicated with a recombination value of 36.65% 
+ 5.9 at the 5% confidence level. This would give a position near to 
fuzzy (Fz) (the proximal position), or Pep-3 and leaden (ln) 
(the distal position), making chromosome 1 a strong candidate for Pk-1. 
Pk-3 maps close to dilute (d) (Johnson et al., 1980), the 
paralogous gene to d on chromosome 1 is leaden (in), one of the 
positions indicated by the Idh-1 linkage data. In this study the 
mapping of Pk-1 to chromosome 1 has been approached using two 
methods. 
First, the results obtained in Chapter 7 on the BXH recombinant 
inbred strains were analysed for co-segregation to chromosome 1 marker 
enzymes. 
Second, linkage to leaden (in) was determined by the segregation 
of the Pk_lb  and  Pk_la  alleles with wild type Mn) and leaden 
(in) coat colours. 
9.2 Results and Discussion 
9.2.1 Mapping using the BXH recombinant inbred strains 
As described in section 6.1 recombinant inbred strains can be used to 
determine whether a phenotypic difference between the progenitor 
strains is controlled by a single gene. If enough strains are 
available, the strain distribution pattern (SDP) can be used for 
mapping purposes. 
The structural gene difference between the C57BL/6 and C3H/He 
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inbred strains for liver PK enzyme (Fig. 9.1) was used to classify 12 
BXH recombinant inbred strains (see Chapter 7). Each strain was 
classified as having either C3H/He PK activity or C57BL/6 PK activity. 
All the strains could be classified with the exception of strain 14 
(Table 9.1). Liver samples for BXH-14 were received in two vials. 
Livers from vial 1 were all C3H/He PK activity, whilst from vial 2 the 
livers were all C57BL/6 activity. Further livers from BXH-14 animals 
will have to be analysed when they have been received. 
The data from the BXH strains were analysed by Dr B. Taylor, 
Jackson Laboratory. The following possible linkages to chromosome 1 
markers were found. 
From the 11 BXH strains 2 crossovers occurred between Pk-1 and 
Emv-17 and 1 crossover between Pk-1 and Stw-1 (Fig. 9.2). Both 
of these loci map to chromosome 1 in the region where a gene 
parallogous to Pk-3 might be expected to be found. As only 11 strains 
were available, it is not possible to say positively that there is 
linkage. The results are not however inconsistent with linkage and 
would be supportive evidence if further linkage could be detected by 
other means. With the view to gaining such evidence linkage to the coat 
colour locus leaden (in) was tested. 
9.2.2 Linkage of the Pk-1 locus to the leaden (in) coat colour locus 
As discussed in the introductory section to this chapter, a potential 
position for the Pk-1 locus would be on chromosome 1 near to the 
leaden (in) coat colour locus. The results from the analysis of the 













Increasing volume of enzyme 
Fixed volume of antiserum 
FIGURE 9.1 
A representation of the immunoprecipitation results for C57BL/6 
and C3U/He, from the results described in Section 5.2. 
TABLE 9.1 Strain distribution analysis of the BXH 
recombinant inbred strains 
Strain 	PK activity (mu mg- I 	Phenotype 
wet wt.) + S.E. 
C57BL/6J 	57.0 ± 2.8 	 B 
C3H/J 	 36.6 + 1.1 	 H 
BXH 2 37.1 + 1.4 	 H 
BXH 3 38.4 + 2.0 	 H 
BXH 4 37.4 + 4.4 	 H 
BXH 6 80.3 + 1.7 	 B 
BXH 7 35.3 ± 3.0 	 H 
BXH 8 68.8 + 3.5 	 B 
BXH 9 60.1 + 1.7 	 B 
BXH 10 38.5 + 2.5 	 H 
BXH 11 43.1 + 1.5 	 H 
BXH 12 42.5 ± 3.5 	 H 
BXH 14 - 
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FIGURE 	9.2 • 	Mouse 	chromosomes 1 	to 10. 	ChromosotS 	
1, 	7 and 9 are believed to be three of a set of 
parallogouS chromosomes. Emv-1 
Pk-3, in and d are indicated by arrows. 
BXH recombinant inbred strains is consistent with this map position. 
Linkage of a Pk-1 structural gene variant to the leaden locus 
would however confirm this position. 
C57L has the leaden coat colour and wild type PK-L and PK-R 
activity (Pkla). W (Pk_lb/Pk_lb) has wild type coat 
colour (Ln) and a heat labile PK-L and PK-R (Pk_lb) enzyme 
(Table 9.2). 
The F 1 generation from a cross between C57L and W was backcrossed 
to the recessive parent, C57L. C57L and W also differ at two other 
coat colour loci, C57L is recessive at all three (Table 9.3). Thus in 
the backcross to C57L there are eight possible combinations of coat 
colour genes. 
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TABLE 9.2 Specific activities of PK-L and PK-R in C57L and W + S.E. 
Liver 	 Blood 
Pk_1a,Pk_1 (C57L) 
	
56.5 + 2.5 	7.4 + 0.27 
Pk_lb/Pk_lb (w) 
	
17.82 + 1.08 	3.13 + 0.33 
TABLE 9.3 Coat colour loci for C57L and W 
Locus Agouti (a) Brown (b) Leaden (in) 




1 	A B Ln agouti 
2 	A b Ln agouti brown 
3 	A B in agouti leaden 
4 	A b in agouti brown leaden 
5 	a B Ln black 
6 	a b Ln chocolate 
7 	a B in leaden 
8 	a b in brown leaden 
If Pk-1 and in are linked, leaden animals would have the same 
liver PlC activity as C57L animals, (high), and non-leaden animals a 
liver PlC activity the same as W animals, (low). Although with care all 
the colour combinations can usually be distinguished some mice proved 
difficult to classify. To avoid any misclassification affecting the 
results, only the phenotypes a b Ln (chocolate) and a B Ln 
(black) have been shown on the histograms (Figs. 9.1 & 9.2). Both 
phenotypes are Ln and if linked to Pk-1 would have the Pk-1
b  
PlC activity. The results for liver and blood (Figs. 9.3 & 9.4) show 
animals with black and chocolate coats to be spread over the whole 
range of PlC activities. However the number of animals is small and for 
the liver results the dividing line between F 1 type and leaden type 
animals is arbitrary. Two alternative divisions are given in Figure 
9.3. One indicates no linkage, the other possible linkage. A larger 
number of animals is needed to clarify the situation. These results 
are consistant with the results obtained in a parallel experiment to 
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FIGURE 9.3. 
Segregation analysis of C57 Leaden and W (Pk_lb/Pk_lb) 
in liver. 
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FIGURE 9.4. 
Segregation analysis of C57 Leaden and 
W (Pk_lb/Pkib ) in blood. 
indicated in Chapter 7 (Appendix B). 
As linkage of Pk-1 to leaden was not established, a new mapping 
strategy must be used. The recombinant inbred strains BXD derived from 
C57BL/6 aand DBA/2 are a powerful tool for mapping as 27 strains exist, 
all of which have been classified for several hundred marker enzymes. 
To map Pk-1 using these strains requires a structural difference 
between C57BL/6 and DBA/2 to be found. So far no such difference has 
been identified by conventional biochemical techniques. The techniques 
of molecular genetics provide a new tool for looking at structural 
differences. A single base change, if it occurs at a restriction 
enzyme binding site, between two strains can be identified using 
Southern blotting. Such a structural difference produces different 
restriction patterns - on Southern blots and are referred to as 
restriction fragment length polymorphisms (RFLP). Initial studies to 





Molecular Genetics: Restriction Fragment Length 
Polymorphism between C57BL/6 and DBA/2 
10.1 Introduction 
Modern developments in recombinant DNA technology have provided many 
new means of investigating structural differences between genes. In 
order to map a gene using recombinant inbred strains, (RI's), it is 
necessary to find a structural difference between the gene of interest 
in one progenitor and that in the second progenitor. The BXD RI 
strains are one of the most powerful mapping tools because of the 
number of strains available (27). A structural difference is therefore 
necessary between the Pk-1 gene in C57BL/6 and Pk-1 in DBA in 
order for this gene to be mapped using the BXD strains. Biochemical 
analysis has not produced any differences between these two strains 
either in activity, kinetics, electrophoretic mobility or heat 
stability, however a difference may occur at the DNA level without 
altering any of the biochemical parameters. 
Fragments of DNA can be produced by digesting the DNA with a 
restriction enzyme. Restriction enzymes are found in bacteria and are 
a defence mechanism by which foreign DNA is digested. The enzymes 
recognise a specific sequence of bases - the binding site - and then cut 
the DNA either at that site or at a second specific restriction site. 
For example the restriction enzyme EcoRI, derived from E. coli, 
restricts DNA in the following manner. 
ITT C 
C rrAA G 
---G 	AATTC--- 
--- crAA 	C---- 
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A single base change will prevent the restriction enzyme from working. 
Thus if a piece of DNA originally had 2 restriction sites and lost one, 
the number of fragments would change from three to two changing the 
restriction fragment pattern when the pieces are separated on a gel. 
Differences in restriction fragment patterns for the same gene are 
called restriction fragment length polymorphisms (RFLP's). 
To find RPLPs, genomic DNA from the two strains being investigated 
is digested by a variety of restriction enzymes. The fragments are 
separated on gels and transferred to nitrocellulose by Southern 
blotting. The gene in question is then identified by hybridising the 
filter to radioactive complementary DNA. Thus it is necessary to have 
a source of cDNA for the gene. cDNA to PK-M and PK-L was provided as 
inserts in the plasmid pBR322 by Professor P. Tanaka (Osaka). The PK-M 
cDNA and PK-L cDNA do not crosshybridise under the stringency 
conditions used. 
Plasmid was prepared and purified using standard techniques 
(Maniattis, 1982), radioactive cDNA was prepared using random priming 
(Feinberg & Vogelstein, 1983, 1984). Southern blots were prepared and 
hybridised using standard techniques (Maniattis, 1982). DNA was 
digested with a variety of restriction enzymes until one was found 
which produced a RFLP. 
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10.2 Results 
Initially the following restriction enzymes were used to look for 
RFLP's. EcoRl, Hindill, BamHI, Sau3A and Sail. Of these EcoRI was the 
only one which showed any indication of a polymorphism (Fig. 10.1). 
This however is a very small difference and may be an artifact. 
Reproducibility is the most important feature when looking for 
polymorphisms and to date this has not yet been shown to be the case. 
Because the difference is so small, screening will be continued in 
order to find a more suitable polymorphism. This will then be used to 
screen BXD livers to map the Pk-1 gene. It is proposed that the 
technique will then be extended to other strains, e.g. MUN, SWR, C3H, 
in order to accurately assess linkage, to the structural locus, of the 
regulatory loci. 
If a suitable polymorphism for C57BL/6 and DBA is not found 
another means of mapping which could be used is to screen for a 
polymorphism with Mus spretus. A series of backcross animals from a 
Mus spretus/C57BL cross have been analysed for marker enzymes (J.L. 
Guenet and F. Bonhomme, see for example Robert et al., 1985 ). This 
means of mapping is however limited by the amount of material 






Possible restriction fragment length polymorphism for Pk-1. A southern blot of 




Gene expression in eukaryotes is influenced by a wide variety of 
mechanisms including differential transcription and variable 
utilization of mRNA transcripts. Multigene families of genes, coding 
for similar or identical proteins, are another mechanism by which the 
amount, diversity and timing of gene expression is regulated. The 
present level of understanding of gene expression in eukaryotes is 
attributable mainly to biochemical and molecular techniques rather 
than to traditional genetics. This is partly due to lack of enzyme 
activity variants of a large enough magnitude to allow genetic 
analysis, and also the difficulty in performing fine structure mapping 
in mammals. Extensive screening of wild and laboratory mice has 
however now produced enzyme activity variants of sufficiently large 
effect to allow detailed genetic analysis of a few systems. An example 
of a system in which extensive genetic variation has been found by 
screening is pyruvate kinase. 
Pyruvate kinase provides a useful model system as its expression 
is controlled at several levels. 
Activation/deactivation of a specific gene in a tissue specific 
manner, i.e. the selection of Pk-1 or Pk-3 expression in a 
particular tissue type. 
Developmental changes in the levels of expression of the two 
109 
110 
genes, e.g. Pk-3 to Pk-1 in foetal/adult liver. 
Differential mRNA transcription and/or processing to produce a 
specific protein in a tissue specific manner, e.g. PK-R or PK-L from 
the Pk-1 gene. 
Differential concentration of enzymes amongst tissues (for example 
by different levels of transcription or protein turnover), e.g. the 
expression of Pk-3, Muscle > Kidney > liver. 
Hormonal control, e.g. the effects of insulin (positive) and 
glucagon (negative). 
Nutritional control. The nutritional status affects pyruvate kinase 
levels, e.g. in fasted animals the level is low, in refed animals, 
high. 
To analyse this system, the different regulatory elements have to 
be identified and their inter-relationships analysed. Putative 
regulatory mutations were found by screening wild and laboratory mice 
for PK-R activity variation. Thus, because of the screening technique, 
the present analysis is limited to the Pk-1 gene. 
11.2 Biochemical and genetical analysis of Pk-1 
The variants were analysed biochemically to determine whether they 
were due to alterations in V max or to changes in enzyme 
concentration and genetically by segregation analysis. From these 
analyses it should be possible to answer the following questions: 
The nature of the activity variant (structural or regulatory) 
Linkage of regulatory genes to the structural gene (Pk-1) 
Interaction of the regulatory mutations 
Mapping of Pk-1. 
The activity variants (Table 11.1) were maintained as true 
breeding phenotypes in the laboratory. An initial analysis (by other 
workers) of MTJN and W was completed before the present project was 
undertaken. 
The W phenotype was analysed and described as a structural gene 
mutation designated Pk-lb with the enzyme having a decreased Vmax 
and increased heat lability (Moore, 1981; Moore and Bulfield, 1984). 
The MUN phenotype was analysed and described as a single gene 
mutation which behaved codominantly in segregation with C3H/J (Charles 
and Pretsch, 1984). 
The present analysis was begun with the biochemical 
identification, using irnmunoprecipitation, of the phenotypes into 
structural gene mutations or regulatory gene mutations (Chapter 5). 
PKD and PKL were identified as structural gene mutations and the 
following nomenclature given: 
PKD - Pk_l sC 
PKL - Pk_lsd 
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Table 11.1 Activity variants in pyruvate kinase (Pk-1) 
expressed as a percentage of the activity found in 
C5 7BL/6 
Phenotype 	 Activity 	 Source 
(Percentage of C57BL/6) 
Liver 	 Blood 
C57BL/6 100 100 Laboratory inbred 
W 25 41 Wild (Leicester) 
PKD 35 70 Wild (Edinburgh) 
PKL 43 65 Wild (Leicester) 
C3H/He 50 100 - 	 Laboratory inbred 
MUN 115 220 Mutation of(tOfCjfF 
SWR 40 100 Laboratory inbred 
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The other phenotypes proved to be more complex. The results 
expressed below refer to Pk-1 only and with C578L/6 as the 
standard phenotype (Chapters 6 and 7). 
C3H/He: A tissue specific decrease in V max 
 in the liver was 
observed with no alteration in enzyme number. 
MUM: 	Tissue specific decrease in V max 
 in the liver was 
-  
observed with a systemic increase in enzyme number. 
SWR: 	V 	was unaltered in both tissues but a decrease in - max 
enzyme number was observed in the liver. 
Thus the phenotypes can be classed genetically as follows: 
Phenotype 	 Nomenclature 
W 	 Systemic structural 	
Pk_lsb 
	
PKD 	gene mutation 	
Pk_lsC 
PKL 	 Pk-1s 
1 
C3H/He 	Tissue specific 	 Pk-1s 
structural gene mutation 
MUM 	Tissue specific 	 Pk-1s1 
structural gene mutation 
Systemic regulatory 	 Pk-lr a-m 
gene mutation 





The electrophoretiC variant of PK found in Mus spretus (F. 
Bonhomme, personal communication) was named Pk_lsS. 
It must, however, be noted that the decreases observed in PK 
activity are not equal (with respect to C57BL/6 levels) in liver and 
blood. The liver decrease is higher in all three cases showing a 
systemic decrease in activity. If the activities are expressed as a 
percentage of C3H/He however (Table 11.2), this difference is 
reduced. 
The conclusion which can be drawn from this is that the C311/He 
structural gene is nearer to the wild type (as represented by W, PKD 
and PKL) whilst C57BL/6 and SWR carry a mutation in the exclusive 
liver exon. 
However, as C57BL/6 and W have already been referred to in the 
literature as Pk_la and Pk_lb respectively, C57BL/6 will continue 
to be referred to as the standard phenotype. It must be noted that the 
difference between Pk_lSa and the three structural gene mutations 
_15b, Pk_lSc and Pk_lsd may involve two mutations; one in the exon, 
which is exclusively expressed in the liver, and one which results in 
a systemic decrease in V max 
Table 11.2 Activity variants of pyruvate kinase (Pk-1) expressed 
as a percentage of the level in C3H/He 
Phenotype 	 Activity 
(Percentage of C3H/He) 
Liver 	Blood 
C57BL/6 200 100 
W 50 41 
PKD 70 70 
PKL 86 65 
C3H/He 100 100 
MUN 230 220 
SWR 80 100 
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From the segregation analysis of the phenotypes it was possible to 
define the mutations as single gene mutations or otherwise, to 
determine the linkage of the structural gene to the regulatory genes 
and to determine whether the SWR and MUN regulatory gene mutations 
behaved allelicly. The inter-relationships are represented 
diagrammatically in Figure 11.1. 
The evidence from Chapters 6, 7 and 8 is consistent with the 
phenotypes being due to a number of single gene mutations, although in 
several crosses the activity also seems to be affected by a number of 
modifier genes and by the presence of possible recombinants or 
background "noise". The SWR phenotype in particular appears to be 
affected by modifiers. The segregation analyses also suggest that the 
regulatory genes identified in SWR and MUN are located at, or near to, 
the structural gene. Analysis of this system has been taken as far as 
possible using enzyme activity as a parameter. 
The conclusions could be confirmed by the following experiments: 
( 1 ) The use of restriction fragment length polymorphisms (RFLP5) as a 
structural gene marker independent of activity. 
(2) The use of congenic lines to reduce the effect of modifier genes 
and variable genetic background on the activity phenotype. 
If RFLPs are found between C57BL/6 and DBA/2, it should then be 
possible to map Pk-1 using the BXD recombinant inbred strains. If 
RFLPs between C57BL/6 and DBA/2 are not found, an alternative mapping 
PKD 	 PKL 
r 
Systemic structural gene mutation 
C57BL/6 
Systemic Tissue specific 
gene mutation 	
structural gene mutation regulatory gene mutation 
W 	C3H/He 	 SWR 
Systemic regulatory gene mutation 
\I : 
MUN 
ENU .induced mutation 
(10 1 /E 1 xC3H/E 1).F 1 
Figure 11.1 A diagrammatic representation of the inter-
relationships between the phenotypes. 
strategy would be to use the backcross lines derived from Mus 
spretus x Mus musculus (Robert et al., 1985). 
11.3 Nomenclature 
The following nomenclature has been given to the putative structural 
and regulatory genes so far identified. The MUM and SWR regulatory 
gene mutations have been treated as alleles of a single regulatory 
locus as they behave as alleles in crosses. 






C3H/He Pk-1s 1 (liver only) 
MUM Pk-1s 1 (liver only) 
SWR Pk_lSa 
Mus spretus (MS) Pk_lsS (electrophoretic) 
11.3.2 Regulatory gene mutations 
Strain/Phenotype 	 Allele 
C57BL/6,W,PKD,PKL,C3H 	 Pk_lra 
MUM 	 Pk-lr a-rn 










Pk-1s a, Pk-1r a  
Pk_l sb , Pk_l ra 
Pk-ls
c 
 , Pk-lr a  
Pk_l sd , pk_l ra 
Pk-1s1, Pk_lra 
Pk-1s1, Pk_lram 
Pk_l Sa , pk_l rb 
Pk-1 Haplotype 
As the regulatory gene has been shown to be at or near the structural 
locus, each phenotype can now be described as an haplotype of a gene 
complex, consisting of a structural locus (Pk-1s) and at least one 
regulatory locus (Pk-1r). 
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11.4 Summary 
11.4.1 The following phenotypes were confirmed as structural gene 
mutations affecting both the PK-R and PK-L enzyme (Chapter 5): 
Phenotype 	 Haplotype 
W 	 Pkls', pklra 
Pk_1 5c , pkl ra 
PKL 	 Pk_lsd, Pk- lra 
11.4.2 C3H/He was shown to have a structural gene difference affecting 
the PK-L enzyme only, when compared to C57BL/6. A possible explanation 
would be if the two strains had a mutational difference in the exon 
exclusive to PK-L mRNA (Chapters 5 and 7) (Noguchi et al., 1986). 
11.4.3 MUN and SWR were shown to be single regulatory gene mutations 
(though affected by modifier genes) (Chapters 6, 7 and 8), which 
interact codominantly and behave in crosses as alleles of a single 
regulatory locus. 
11.4.4 The regulatory gene was shown to be at, or near, the structural 
gene (Chapters 7 and 8), although the exact degree of linkage cannot 
be determined until a structural marker (e.g. RFLP or usable 
electrophoretic marker) has been found. If the regulatory gene is 
close to the structural gene, it is likely to be very close, as has 
been observed for other linked regulatory genes, e.g. the acid 
hydrolases gene complexes and histidine decarboxylase (Middleton et 
al., 1987; Paigen, Review 1979), and is unlikely to be separable by 
formal genetic segregation analyses. If, however, true recombinants 
are observed, it would imply only loose linkage of the regulatory gene 
to the structural gene, and it would no longer be possible to describe 
the system as a gene complex. Loose linkage would also imply that the 
action of this regulatory locus would most probably be trans-acting as 
has been observed for other non-linked regulatory genes such as the 
Rif/raf system which regulates Qfetoprotein (Belayew and Tilghman, 
1982) and many other distant regulators (Paigen, Review 1979; Berger 
et al., 1979). If the regulatory locus does prove to be tightly 
linked, the most common mode of action for such a system is a cis-
acting one with the effect being mediated via the DNA. However it must 
be noted that a closely linked trans-acting regulatory gene has been 
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described for the temporal regulatory locus of the[ -glucuronidase 
gene complex (Lusis et al.., 1983). 
The closeness of the linkage between the regulatory and structural 
genes could be further investigated by the derivation of congenic 
lines and by the availability of a usable structural genetic marker. 
This would also allow mapping of the loci using recombinant inbred 
lines. 
11.5 General Discussion 
This present work, along with that of others (Paigen, Review 1979; 
Middleton et al., 1987), shows the existence of a considerable 
degree of putative regulatory gene polymorphism existing in both wild 
and inbred populations of mice. Also that the final enzymic phenotype 
is affected by a variety of parameters such as temporal regulation, 
tissue specific regulation, systemic regulation and response to 
hormones, all of which are presumably mediated by one or more specific 
regulatory genes. 
Many of these regulatory genes have been shown to cluster at the 
structural gene forming gene complexes, which then form an active unit 
of functional organisation. The data from the present experiments with 
pyruvate kinase is in accordance with these findings with a regulatory 
gene being identified at, or near to, the structural gene. 
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Screening of wild and laboratory strains of animals has shown that 
gene pools vary considerably from population to population, and a 
particular haplotype may be predominant in a particular population. 
This has been shown, for example, with histidine decarboxylase where 
mice derived from a Danish population have novel alleles at the 
structural gene and three regulatory genes (Middleton et al., 1987). 
The method of screening adopted for PK variants has produced 
regulatory mutants but, of necessity, these are restricted to such 
variation of the Pk-1 gene as can be detected in the blood of 
animals. Screening of inbred strains may identify Pk-3 mutants or 
mutants in hormonal and temporal response. Such mutants would allow 
the identification of further regulatory loci either in the gene 
complex or as distant regulators. 
Another feature often observed in gene complexes is that of 
linkage disequilibrium (the non-random assortment of alleles in the 
complex), for example infr_glucuronidase (Paigen and Noell, 1961), 
although it is not seen in _galactosidase (Breen et al., 1979). Too 
little data is as yet available to say if this phenomenon also occurs 
in the pyruvate kinase gene complex. 
Not all regulatory genes however reside at the structural gene, 
e.g. non-specific regulators such as protein receptor molecules. 
Temporal regulators also are often (but not always) distant from the 
structural gene (Berger et al., 1979). 
Interestingly, distant regulator, though by necessity trans-
acting, do not show dominant/recessive genetics, which would be 
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inferred from prokaryotic genetic regulation. Instead all appear to 
show additive genetics which has interesting implications on their 
mode of action. 
A trans-acting regulatory gene has also been described which is 
found to be closely linked to the structural gene as part of the gene 
complex, this is the temporal gene of the _glucuronidase gene complex 
(Lusis et al., 1983), this too shows additive inheritance of its 
alleles. This is of interest when the SWR regulatory phenotype is 
considered, as, in some crosses, its effect appears to be dominant 
(Chapters 6 and 8), which is not in agreement with the data just 
described. However this effect does not appear in all crosses and may 
be due to modifier genes or "noise " , this may be clarified if crosses 
with congenic lines were carried out to remove background noise. The 
true interaction of the regulatory alleles could then be observed. 
11.6 Conclusions 
Pyruvate kinase has been shown to have complex regulation which is 
likely to involve several regulatory loci. At least one regulatory 
gene has been identified, Pk-1r, which resides at, or close to, the 
structural gene, forming a gene complex. This is in accordance with 
other genes with complex regulation and whose main functional unit is 
the gene complex. Further regulatory variants could be looked for by 
widening the method of screening in order to find Pk-3 variants, 
temporal variants and hormonal response variants. The individual 
elements of the gene complex could then be established. Analysis at 
the molecular level should enable regulatory sequences and modes of 
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action to be established and to identify the means by which Pk-1 and 
Pk-3 are tissue specifically selected. 
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APPENDIX A 
A statistical analysis of the C57BL/6 and SWR crosses 
(Elston, personal communication ) 
Methods 
Elston (1984) presented a maximum likelihood method of analyzing a 
quantitative trait measured on two inbred parental strains, their Fl, 
and their backcross generations, with a view to choosing amongst a set 
of simple genetic hypotheses to account for the observed variability 
in the trait. The data are first transformed by a power 
transformation, if possible, to achieve approximate normality and 
homoscedasticity of the parental and Fl generations. Likelihoods are 
then calculated from all the data, maximizing over unknown parameters, 
for a series of genetic hypotheses - one locus, polygenic, mixed major 
locus/polygenic, two unlinked loci, and two linked loci. In each case 
it is assumed that the variability about any genotypic mean is 
normally distributed with a common variance. A likelihood is also 
calculated for a general model that subsumes each specific hypothesis 
as a special case. For example, the general model contains a 
paraxneter,A , such that)( = 1 corresponds to the mixed major gene/ 
polygenic hypothesis,A = 1/2 corresponds to two unlinked loci, and 
o < A < 1/2 corresponds to two linked loci. Then significant departure 
from any specific hypothesis is judged by comparing the natural 
logarithm of the likelihood under that hypothesis with the natural 
logarithm of the likelihood under the general model; twice the 
difference between these two quantities is, in large samples, 
distributed as chi-square if the hypothesis is true. One can also 
choose the "best" hypothesis using Akaike's (1977) AIC information 
criterion. In this method one basically selects the hypothesis that 
gives rise to the largest likelihood as being the best, except that 
allowance is made for the fact that under different hypotheses the 
likelihood is maximized over different numbers of parameters. Elston 
(1984) listed 37 specific hypotheses, each being defined by a 
particular set of constraints on the parameters of the general model. 
These hypotheses were all examined, both for significant departure 
from the general model and for comparison with each other via the AIC 
information criterion. 
Results - PK 
initial analysis of the C57BL/6, SWR and their Fl data 
indicated that these three classes are not significantly 
heteroscedastic (A = 2.81, 2d.f., p > 0.2), and that the 
best power transformation to obtain normality and 
homoscedasticity is x = y 939 . 
An analogous analysis of the six RI strains similarly 
indicated lack of significant heteroscedasticity (J( = 
6.70, 7d.f., p > .5), and the power transformation was 
estimated to be x = y 25 . 
Based on the results of this initial analysis, the data on 
C57BL/6, SWR, Fl and their backcross offspring were 
analyzed after undergoing a logarithmic transformation, 
which corresponds to a power of zero. The hypothesis that 
is most compatible with the data, based on Akaike's AIC 
criterion, is one in which two linked loci are segregating. 
However, examination of the parameter estimates for that 
hypothesis show A= 0.89, i.e., a "recombination fraction" 
of 0.89. Since this is biologically unrealistic, the next 
best hypothesis is one in which both a major gene and 
polygenes are segregating, i.e., the so-called "mixed 
model", and that the chi-square for that hypothesis is not 
significant (X2 = 7.59, 3d.f., p > .05). All other 
hypotheses - single gene, polygenic or two unlinked loci - 
are rejected with p < .01. 
q. 
There is significant departure from the general mixed major gene/ 
polygenic hypothesis 
(A2 
= 7.55, 2df., p 	.02), in which seven 
distinct means are estimated: means for C57BL/6, SWR and their Fl, two 
corresponding means for the C57BL/6 x Fl backcross (but displaced 
because of polygenic effects), and two corresponding means for the SWR 
x Fl backcross (also displaced). However, two of the means are 
estimated to be almost identical, and when a symmetrical relationship 
(Symmetry B of Elston (1984)) is imposed on the means, the estimates 
remain virtually unchanged. Thus the chi-square for fit of the model 
increases only slightly (to 7.59) but, because of the additional 
degree of freedom gained, is no longer significant. The parameter 
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It should be noted that whereas the C57BL/6 x Fl backcross 
segregates into two groups (with means 4.46 and 4.11 - displaced from 
4.38 and 3.89 by polygenic effects), there is no such segregation in 
the SWR x Fl backcross. The similarity of the single backcross mean 
(3.84) to the Fl mean (3.89) is peculiar. 
The analysis was repeated after using the transformation x = 
.039 
y 	and obtained essentially the same results. The same mixed 
model is the only one to fit the data, though the fit is slightly 
better (y? = 7.38, 3d.f.). The estimates show the same peculiarity - 
the two SWR x Fl backcross means are identical, and almost equal to 
the Fl mean. 
APPENDIX B 
An investigation into the possible linkage between 
pyruvate kinase and leaden coat colour - 6th Form Project 
M. Davison, Penicuik High School, Penicuik, Midlothian 
Supervisors: L. Fitton and G. Bulfield 
The graphs that follow show the pyruvate kinase activity of the 
samples assayed. 
The top graph in each case shows the specific activity of the C57L 
and Munich mice in either the blood or liver. 
The middle graph shows the specific activity of the Fl generation, 
again this appears on each graph. The activity being in the liver or 
the blood. 
The bottom graph shows the specific activity of pyruvate kinase in 
the blood or liver of a backcross to c57L or Munich as stated. 
FIGURE 1 - Pyruvate kinase activity in the blood. 
Graph a shows the activity of the C57L and the Munich mice in the 
blood. The pyruvate kinase activity for these animals falls into 2 
distinct groups. 
Graph b shows the activity of the Fl generation from a cross of the 
above. The pyruvate kinase activity is intermediate of the two. This 
shows co-dominance. 
Graph c is the activity of the animals from the backcross to c57L 
(LLM). This backcross does not show segregation but is grouped 
together. The animals with leaden coat colour are randomly distributed. 
Taking as the point of segregation between 9 and 10 the recombination 
percentage can be calculated (see Introduction). 
Recombinants: 1. Animals with pyruvate kinase activity < 9, non-leaden. 
2. Animals with pyruvate kinase activity > 9, leaden. 
no. of animals = 5 
no. of animals = 6 
Recombinants 	= 11 
Recombination percentage = 	recombinants 
Total no. of animals 
= 11 x 100 
27 
= 40.7% 
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FIGURE 2 - Pyruvate kinase activity in the liver. 
Graph a is the activity of the C57L and Munich in the liver. Again 
they fall into 2 separate groups (segregate). 
The activity of the Fl is again intermediate, this shows that the 
difference in pyruvate kinase activity in the liver also shows co-
dominance. 
Graph c shows the activity of the animals produced from the backcross 
to C57L. In this backcross the pyruvate kinase activity clearly 
segregates. This confirms the fact that it is behaving as a single 
gene. The animals with leaden coat colour are randomly distributed as 
in Figure 1, graph c. 
Taking as the point of segregation just before 80 the recombination 
percentage can be calculated. 
Recombinants: 	1. Animals with pyruvate kinase activity < 80, non- 
leaden coat colour. 
2. Animals with pyruvate kinase activity > 80, leaden 
coat colour. 
no. of animals = 7 
no. of animals = 4 
Recombinants 	= 11 
Recombination percentage = 
	recombinants 
Total no. of animals 
= 11 x 100 
27 
= 44% 
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FIGURE 3 - Pyruvate kinase activity in the blood. 
Graph a and b are the same aê in Figure 1. 
Graph c shows the activity of the animals from a backcross to Munich. 
There is a hint of segregation in this backcross although it is 
unclear exactly where it occurs. There are animals in this backcross 
that have a greater kinase activity than that of Munich. In this 
backcross no animals show leaden coat colour as leaden (in) is 
recessive. 
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FIGURE 4 - Pyruvate kinase activity in the liver. 
For graph a and b see Figure 2. 
Graph c shows the pyruvate kinase activity of the animals from the 
same backcross as Figure 3 although in this case the pyruvate kinase 
activity is measured in the liver. 
The pyruvate kinase activity segregates clearly as in Figure 2, 
behaving as a single gene. No animals show leaden coat colour as 
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